GO Terms |
Score |
Description |
GO:0008150 |
97.10% |
biological_process |
GO:0065007 |
95.13% |
biological regulation |
GO:0050789 |
95.01% |
regulation of biological process |
GO:0050794 |
94.48% |
regulation of cellular process |
GO:0019222 |
93.60% |
regulation of metabolic process |
GO:0060255 |
93.57% |
regulation of macromolecule metabolic process |
GO:0010468 |
93.37% |
regulation of gene expression |
GO:0080090 |
93.33% |
regulation of primary metabolic process |
GO:0031323 |
93.19% |
regulation of cellular metabolic process |
GO:0019219 |
93.16% |
regulation of nucleobase-containing compound metabolic process |
GO:0051171 |
93.11% |
regulation of nitrogen compound metabolic process |
GO:0009889 |
92.96% |
regulation of biosynthetic process |
GO:0010556 |
92.80% |
regulation of macromolecule biosynthetic process |
GO:0051252 |
92.57% |
regulation of RNA metabolic process |
GO:0031326 |
92.51% |
regulation of cellular biosynthetic process |
GO:1903506 |
92.45% |
regulation of nucleic acid-templated transcription |
GO:2000112 |
92.44% |
regulation of cellular macromolecule biosynthetic process |
GO:0006355 |
92.14% |
regulation of transcription, DNA-templated |
GO:2001141 |
92.11% |
regulation of RNA biosynthetic process |
GO:0032502 |
87.88% |
developmental process |
GO:0006357 |
87.56% |
regulation of transcription by RNA polymerase II |
GO:0009987 |
76.63% |
cellular process |
GO:0048856 |
74.45% |
anatomical structure development |
GO:0048869 |
73.71% |
cellular developmental process |
GO:0009653 |
68.30% |
anatomical structure morphogenesis |
GO:0030154 |
66.27% |
cell differentiation |
GO:0048522 |
61.68% |
positive regulation of cellular process |
GO:0032501 |
61.48% |
multicellular organismal process |
GO:0048518 |
61.32% |
positive regulation of biological process |
GO:0051254 |
58.27% |
positive regulation of RNA metabolic process |
GO:0010557 |
58.21% |
positive regulation of macromolecule biosynthetic process |
GO:0045935 |
58.17% |
positive regulation of nucleobase-containing compound metabolic process |
GO:0010628 |
58.15% |
positive regulation of gene expression |
GO:0009891 |
58.14% |
positive regulation of biosynthetic process |
GO:0031328 |
57.83% |
positive regulation of cellular biosynthetic process |
GO:0051173 |
57.76% |
positive regulation of nitrogen compound metabolic process |
GO:0031325 |
57.37% |
positive regulation of cellular metabolic process |
GO:0010604 |
57.37% |
positive regulation of macromolecule metabolic process |
GO:1902680 |
57.23% |
positive regulation of RNA biosynthetic process |
GO:0048513 |
57.14% |
animal organ development |
GO:1903508 |
57.14% |
positive regulation of nucleic acid-templated transcription |
GO:0045893 |
57.13% |
positive regulation of transcription, DNA-templated |
GO:0009893 |
56.87% |
positive regulation of metabolic process |
GO:0030182 |
55.93% |
neuron differentiation |
GO:0045944 |
54.54% |
positive regulation of transcription by RNA polymerase II |
GO:0048519 |
53.61% |
negative regulation of biological process |
GO:0007389 |
53.10% |
pattern specification process |
GO:0003002 |
52.27% |
regionalization |
GO:0048523 |
51.23% |
negative regulation of cellular process |
GO:0009892 |
45.15% |
negative regulation of metabolic process |
GO:0010629 |
44.75% |
negative regulation of gene expression |
GO:0010605 |
44.61% |
negative regulation of macromolecule metabolic process |
GO:0031324 |
44.55% |
negative regulation of cellular metabolic process |
GO:0010558 |
44.34% |
negative regulation of macromolecule biosynthetic process |
GO:0031327 |
44.02% |
negative regulation of cellular biosynthetic process |
GO:2000113 |
43.99% |
negative regulation of cellular macromolecule biosynthetic process |
GO:0045892 |
43.98% |
negative regulation of transcription, DNA-templated |
GO:1903507 |
43.98% |
negative regulation of nucleic acid-templated transcription |
GO:0009890 |
43.91% |
negative regulation of biosynthetic process |
GO:0051172 |
43.88% |
negative regulation of nitrogen compound metabolic process |
GO:0051253 |
43.73% |
negative regulation of RNA metabolic process |
GO:1902679 |
43.72% |
negative regulation of RNA biosynthetic process |
GO:0045934 |
43.42% |
negative regulation of nucleobase-containing compound metabolic process |
GO:0000122 |
42.94% |
negative regulation of transcription by RNA polymerase II |
GO:0010941 |
41.63% |
regulation of cell death |
GO:0043067 |
41.59% |
regulation of programmed cell death |
GO:0042981 |
41.45% |
regulation of apoptotic process |
GO:0009952 |
41.20% |
anterior/posterior pattern specification |
GO:0048598 |
38.54% |
embryonic morphogenesis |
GO:0043066 |
38.30% |
negative regulation of apoptotic process |
GO:0009887 |
38.07% |
animal organ morphogenesis |
GO:0043069 |
37.93% |
negative regulation of programmed cell death |
GO:0060548 |
37.24% |
negative regulation of cell death |
GO:0006928 |
37.10% |
movement of cell or subcellular component |
GO:0009888 |
36.71% |
tissue development |
GO:0043523 |
35.59% |
regulation of neuron apoptotic process |
GO:1901214 |
34.87% |
regulation of neuron death |
GO:0035239 |
33.61% |
tube morphogenesis |
GO:0043524 |
32.82% |
negative regulation of neuron apoptotic process |
GO:0048729 |
32.63% |
tissue morphogenesis |
GO:0060429 |
32.49% |
epithelium development |
GO:0048468 |
32.24% |
cell development |
GO:1901215 |
32.13% |
negative regulation of neuron death |
GO:0035295 |
31.91% |
tube development |
GO:0002009 |
31.84% |
morphogenesis of an epithelium |
GO:0022414 |
31.77% |
reproductive process |
GO:0003006 |
31.58% |
developmental process involved in reproduction |
GO:0097485 |
30.77% |
neuron projection guidance |
GO:0009886 |
30.34% |
post-embryonic animal morphogenesis |
GO:0007411 |
29.93% |
axon guidance |
GO:0001709 |
28.75% |
cell fate determination |
GO:0048666 |
27.14% |
neuron development |
GO:0030901 |
26.54% |
midbrain development |
GO:0048608 |
26.15% |
reproductive structure development |
GO:0007444 |
26.04% |
imaginal disc development |
GO:0035282 |
25.88% |
segmentation |
GO:0001708 |
25.54% |
cell fate specification |
GO:0060562 |
25.52% |
epithelial tube morphogenesis |
GO:0048563 |
25.36% |
post-embryonic animal organ morphogenesis |
GO:0008406 |
25.08% |
gonad development |
GO:0035107 |
24.62% |
appendage morphogenesis |
GO:0048646 |
24.44% |
anatomical structure formation involved in morphogenesis |
GO:0050896 |
24.44% |
response to stimulus |
GO:0071840 |
22.49% |
cellular component organization or biogenesis |
GO:0016043 |
22.20% |
cellular component organization |
GO:0050793 |
22.15% |
regulation of developmental process |
GO:0051239 |
22.08% |
regulation of multicellular organismal process |
GO:0048731 |
21.56% |
system development |
GO:0048568 |
21.54% |
embryonic organ development |
GO:0042221 |
21.49% |
response to chemical |
GO:0030030 |
21.46% |
cell projection organization |
GO:0048858 |
21.39% |
cell projection morphogenesis |
GO:0120039 |
21.31% |
plasma membrane bounded cell projection morphogenesis |
GO:0048812 |
21.25% |
neuron projection morphogenesis |
GO:0032990 |
21.01% |
cell part morphogenesis |
GO:0032989 |
20.91% |
cellular component morphogenesis |
GO:0010033 |
20.87% |
response to organic substance |
GO:0035108 |
19.36% |
limb morphogenesis |
GO:0030326 |
19.29% |
embryonic limb morphogenesis |
GO:0035113 |
19.12% |
embryonic appendage morphogenesis |
GO:2000026 |
18.32% |
regulation of multicellular organismal development |
GO:0009953 |
17.81% |
dorsal/ventral pattern formation |
GO:0040011 |
17.77% |
locomotion |
GO:0009954 |
17.52% |
proximal/distal pattern formation |
GO:0016477 |
17.36% |
cell migration |
GO:0045595 |
17.04% |
regulation of cell differentiation |
GO:0048870 |
16.75% |
cell motility |
GO:0003008 |
16.56% |
system process |
GO:0040007 |
16.35% |
growth |
GO:0048589 |
16.33% |
developmental growth |
GO:0051240 |
16.28% |
positive regulation of multicellular organismal process |
GO:0048663 |
16.23% |
neuron fate commitment |
GO:0007409 |
16.22% |
axonogenesis |
GO:0051094 |
16.07% |
positive regulation of developmental process |
GO:0030902 |
16.01% |
hindbrain development |
GO:0030855 |
15.86% |
epithelial cell differentiation |
GO:0071542 |
15.80% |
dopaminergic neuron differentiation |
GO:0007423 |
15.68% |
sensory organ development |
GO:0007610 |
15.66% |
behavior |
GO:0042127 |
15.15% |
regulation of cell population proliferation |
GO:0022603 |
14.85% |
regulation of anatomical structure morphogenesis |
GO:0045165 |
14.62% |
cell fate commitment |
GO:0050877 |
14.58% |
nervous system process |
GO:1901700 |
14.53% |
response to oxygen-containing compound |
GO:0043473 |
14.51% |
pigmentation |
GO:0050770 |
14.40% |
regulation of axonogenesis |
GO:0051716 |
14.25% |
cellular response to stimulus |
GO:0010769 |
13.97% |
regulation of cell morphogenesis involved in differentiation |
GO:0051128 |
13.71% |
regulation of cellular component organization |
GO:0007626 |
13.68% |
locomotory behavior |
GO:0022412 |
13.65% |
cellular process involved in reproduction in multicellular organism |
GO:0035115 |
13.61% |
embryonic forelimb morphogenesis |
GO:0014070 |
13.49% |
response to organic cyclic compound |
GO:0048583 |
13.47% |
regulation of response to stimulus |
GO:0022604 |
13.46% |
regulation of cell morphogenesis |
GO:0060284 |
13.32% |
regulation of cell development |
GO:0030534 |
13.25% |
adult behavior |
GO:0035136 |
13.25% |
forelimb morphogenesis |
GO:0021549 |
13.23% |
cerebellum development |
GO:0048665 |
13.15% |
neuron fate specification |
GO:0009719 |
13.15% |
response to endogenous stimulus |
GO:0070887 |
13.08% |
cellular response to chemical stimulus |
GO:0051093 |
13.08% |
negative regulation of developmental process |
GO:0008344 |
13.03% |
adult locomotory behavior |
GO:0007631 |
12.88% |
feeding behavior |
GO:0001763 |
12.74% |
morphogenesis of a branching structure |
GO:0007165 |
12.72% |
signal transduction |
GO:0050767 |
12.59% |
regulation of neurogenesis |
GO:0061138 |
12.57% |
morphogenesis of a branching epithelium |
GO:0051241 |
12.54% |
negative regulation of multicellular organismal process |
GO:0001654 |
12.38% |
eye development |
GO:0048732 |
12.34% |
gland development |
GO:0051704 |
12.32% |
multi-organism process |
GO:0040012 |
12.28% |
regulation of locomotion |
GO:0045597 |
12.22% |
positive regulation of cell differentiation |
GO:0008152 |
12.10% |
metabolic process |
GO:0071310 |
12.09% |
cellular response to organic substance |
GO:0048754 |
11.93% |
branching morphogenesis of an epithelial tube |
GO:0051960 |
11.92% |
regulation of nervous system development |
GO:0009880 |
11.87% |
embryonic pattern specification |
GO:0048584 |
11.78% |
positive regulation of response to stimulus |
GO:0010975 |
11.76% |
regulation of neuron projection development |
GO:0045596 |
11.76% |
negative regulation of cell differentiation |
GO:0010646 |
11.72% |
regulation of cell communication |
GO:0042472 |
11.66% |
inner ear morphogenesis |
GO:0009966 |
11.53% |
regulation of signal transduction |
GO:0023051 |
11.48% |
regulation of signaling |
GO:0008219 |
11.47% |
cell death |
GO:0044237 |
11.42% |
cellular metabolic process |
GO:0048813 |
11.28% |
dendrite morphogenesis |
GO:0045664 |
11.24% |
regulation of neuron differentiation |
GO:0050890 |
11.23% |
cognition |
GO:0051270 |
11.23% |
regulation of cellular component movement |
GO:2000241 |
11.20% |
regulation of reproductive process |
GO:0040008 |
11.19% |
regulation of growth |
GO:0048736 |
11.19% |
appendage development |
GO:0035114 |
11.16% |
imaginal disc-derived appendage morphogenesis |
GO:0001501 |
11.16% |
skeletal system development |
GO:0060541 |
11.09% |
respiratory system development |
GO:0008284 |
11.09% |
positive regulation of cell population proliferation |
GO:0043068 |
11.07% |
positive regulation of programmed cell death |
GO:0007379 |
11.05% |
segment specification |
GO:0007166 |
11.02% |
cell surface receptor signaling pathway |
GO:0007399 |
11.01% |
nervous system development |
GO:0030334 |
11.00% |
regulation of cell migration |
GO:0007275 |
10.98% |
multicellular organism development |
GO:0048863 |
10.95% |
stem cell differentiation |
GO:0010942 |
10.92% |
positive regulation of cell death |
GO:0048638 |
10.90% |
regulation of developmental growth |
GO:0012501 |
10.86% |
programmed cell death |
GO:2000145 |
10.86% |
regulation of cell motility |
GO:0120035 |
10.82% |
regulation of plasma membrane bounded cell projection organization |
GO:0071704 |
10.74% |
organic substance metabolic process |
GO:0042493 |
10.71% |
response to drug |
GO:0002759 |
10.68% |
regulation of antimicrobial humoral response |
GO:0007611 |
10.65% |
learning or memory |
GO:2000243 |
10.64% |
positive regulation of reproductive process |
GO:0002920 |
10.63% |
regulation of humoral immune response |
GO:0034248 |
10.62% |
regulation of cellular amide metabolic process |
GO:0048562 |
10.57% |
embryonic organ morphogenesis |
GO:0002922 |
10.54% |
positive regulation of humoral immune response |
GO:0043170 |
10.43% |
macromolecule metabolic process |
GO:0021953 |
10.43% |
central nervous system neuron differentiation |
GO:0040020 |
10.42% |
regulation of meiotic nuclear division |
GO:0048609 |
10.42% |
multicellular organismal reproductive process |
GO:1901698 |
10.41% |
response to nitrogen compound |
GO:0010647 |
10.39% |
positive regulation of cell communication |
GO:0009967 |
10.39% |
positive regulation of signal transduction |
GO:0048565 |
10.38% |
digestive tract development |
GO:0061061 |
10.38% |
muscle structure development |
GO:0007167 |
10.36% |
enzyme linked receptor protein signaling pathway |
GO:0071495 |
10.35% |
cellular response to endogenous stimulus |
GO:0023056 |
10.34% |
positive regulation of signaling |
GO:0010720 |
10.32% |
positive regulation of cell development |
GO:0010243 |
10.24% |
response to organonitrogen compound |
GO:0035120 |
10.21% |
post-embryonic appendage morphogenesis |
GO:0051705 |
10.21% |
multi-organism behavior |
GO:0051726 |
10.20% |
regulation of cell cycle |
GO:0007612 |
10.20% |
learning |
GO:0002784 |
10.20% |
regulation of antimicrobial peptide production |
GO:0008045 |
10.18% |
motor neuron axon guidance |
GO:0031344 |
10.15% |
regulation of cell projection organization |
GO:0007281 |
10.07% |
germ cell development |
GO:0065008 |
10.04% |
regulation of biological quality |
GO:0061387 |
9.98% |
regulation of extent of cell growth |
GO:1902742 |
9.96% |
apoptotic process involved in development |
GO:0051703 |
9.94% |
intraspecies interaction between organisms |
GO:0032101 |
9.94% |
regulation of response to external stimulus |
GO:0016070 |
9.93% |
RNA metabolic process |
GO:0043065 |
9.89% |
positive regulation of apoptotic process |
GO:0007417 |
9.87% |
central nervous system development |
GO:0007435 |
9.84% |
salivary gland morphogenesis |
GO:0040018 |
9.82% |
positive regulation of multicellular organism growth |
GO:0007420 |
9.79% |
brain development |
GO:0006915 |
9.78% |
apoptotic process |
GO:0007276 |
9.77% |
gamete generation |
GO:0051445 |
9.76% |
regulation of meiotic cell cycle |
GO:0048806 |
9.71% |
genitalia development |
GO:0008283 |
9.70% |
cell population proliferation |
GO:0009410 |
9.70% |
response to xenobiotic stimulus |
GO:0044238 |
9.68% |
primary metabolic process |
GO:0051301 |
9.67% |
cell division |
GO:0046483 |
9.65% |
heterocycle metabolic process |
GO:0006725 |
9.64% |
cellular aromatic compound metabolic process |
GO:0072347 |
9.61% |
response to anesthetic |
GO:0033043 |
9.58% |
regulation of organelle organization |
GO:0001503 |
9.56% |
ossification |
GO:0042659 |
9.51% |
regulation of cell fate specification |
GO:0051216 |
9.51% |
cartilage development |
GO:0060359 |
9.47% |
response to ammonium ion |
GO:0034250 |
9.45% |
positive regulation of cellular amide metabolic process |
GO:0045927 |
9.44% |
positive regulation of growth |
GO:0030516 |
9.43% |
regulation of axon extension |
GO:0044249 |
9.39% |
cellular biosynthetic process |
GO:1901360 |
9.33% |
organic cyclic compound metabolic process |
GO:0022612 |
9.33% |
gland morphogenesis |
GO:0002064 |
9.32% |
epithelial cell development |
GO:0009725 |
9.31% |
response to hormone |
GO:1901576 |
9.26% |
organic substance biosynthetic process |
GO:0070848 |
9.20% |
response to growth factor |
GO:0009058 |
9.20% |
biosynthetic process |
GO:0042220 |
9.20% |
response to cocaine |
GO:0051785 |
9.19% |
positive regulation of nuclear division |
GO:0045836 |
9.18% |
positive regulation of meiotic nuclear division |
GO:0034641 |
9.18% |
cellular nitrogen compound metabolic process |
GO:0006139 |
9.13% |
nucleobase-containing compound metabolic process |
GO:0009948 |
9.11% |
anterior/posterior axis specification |
GO:0032879 |
9.09% |
regulation of localization |
GO:0009798 |
9.08% |
axis specification |
GO:0051446 |
9.06% |
positive regulation of meiotic cell cycle |
GO:0007530 |
9.06% |
sex determination |
GO:0090304 |
9.04% |
nucleic acid metabolic process |
GO:0007292 |
9.04% |
female gamete generation |
GO:0010564 |
9.02% |
regulation of cell cycle process |
GO:0071363 |
9.02% |
cellular response to growth factor stimulus |
GO:0048477 |
9.01% |
oogenesis |
GO:0048705 |
8.97% |
skeletal system morphogenesis |
GO:0006807 |
8.93% |
nitrogen compound metabolic process |
GO:0001558 |
8.88% |
regulation of cell growth |
GO:0032774 |
8.87% |
RNA biosynthetic process |
GO:1901362 |
8.86% |
organic cyclic compound biosynthetic process |
GO:0048704 |
8.83% |
embryonic skeletal system morphogenesis |
GO:0018130 |
8.83% |
heterocycle biosynthetic process |
GO:0035176 |
8.83% |
social behavior |
GO:0008038 |
8.81% |
neuron recognition |
GO:0051962 |
8.76% |
positive regulation of nervous system development |
GO:0010770 |
8.75% |
positive regulation of cell morphogenesis involved in differentiation |
GO:0035264 |
8.74% |
multicellular organism growth |
GO:0048639 |
8.73% |
positive regulation of developmental growth |
GO:0009059 |
8.71% |
macromolecule biosynthetic process |
GO:0051130 |
8.70% |
positive regulation of cellular component organization |
GO:0045787 |
8.69% |
positive regulation of cell cycle |
GO:0050769 |
8.69% |
positive regulation of neurogenesis |
GO:0019438 |
8.68% |
aromatic compound biosynthetic process |
GO:0051783 |
8.66% |
regulation of nuclear division |
GO:0009605 |
8.62% |
response to external stimulus |
GO:0010453 |
8.56% |
regulation of cell fate commitment |
GO:0002682 |
8.56% |
regulation of immune system process |
GO:0007600 |
8.55% |
sensory perception |
GO:0034654 |
8.53% |
nucleobase-containing compound biosynthetic process |
GO:0001649 |
8.51% |
osteoblast differentiation |
GO:0044260 |
8.48% |
cellular macromolecule metabolic process |
GO:0007519 |
8.47% |
skeletal muscle tissue development |
GO:0043279 |
8.45% |
response to alkaloid |
GO:0060349 |
8.44% |
bone morphogenesis |
GO:0021885 |
8.43% |
forebrain cell migration |
GO:0090068 |
8.43% |
positive regulation of cell cycle process |
GO:0021954 |
8.37% |
central nervous system neuron development |
GO:0044271 |
8.37% |
cellular nitrogen compound biosynthetic process |
GO:0030509 |
8.34% |
BMP signaling pathway |
GO:0061458 |
8.34% |
reproductive system development |
GO:0030856 |
8.29% |
regulation of epithelial cell differentiation |
GO:0010721 |
8.28% |
negative regulation of cell development |
GO:0008037 |
8.27% |
cell recognition |
GO:0045995 |
8.27% |
regulation of embryonic development |
GO:2000177 |
8.26% |
regulation of neural precursor cell proliferation |
GO:0097659 |
8.26% |
nucleic acid-templated transcription |
GO:0007178 |
8.26% |
transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0021795 |
8.23% |
cerebral cortex cell migration |
GO:0010638 |
8.21% |
positive regulation of organelle organization |
GO:0060537 |
8.20% |
muscle tissue development |
GO:0009628 |
8.15% |
response to abiotic stimulus |
GO:0007476 |
8.10% |
imaginal disc-derived wing morphogenesis |
GO:0042461 |
8.09% |
photoreceptor cell development |
GO:0034645 |
8.07% |
cellular macromolecule biosynthetic process |
GO:0006351 |
8.06% |
transcription, DNA-templated |
GO:0045926 |
7.99% |
negative regulation of growth |
GO:0002831 |
7.99% |
regulation of response to biotic stimulus |
GO:0045666 |
7.98% |
positive regulation of neuron differentiation |
GO:0043902 |
7.96% |
positive regulation of multi-organism process |
GO:0048592 |
7.94% |
eye morphogenesis |
GO:0022029 |
7.92% |
telencephalon cell migration |
GO:0010632 |
7.89% |
regulation of epithelial cell migration |
GO:0007507 |
7.87% |
heart development |
GO:0046530 |
7.87% |
photoreceptor cell differentiation |
GO:0090596 |
7.86% |
sensory organ morphogenesis |
GO:0042462 |
7.84% |
eye photoreceptor cell development |
GO:0035148 |
7.84% |
tube formation |
GO:1902667 |
7.82% |
regulation of axon guidance |
GO:0007619 |
7.81% |
courtship behavior |
GO:0010623 |
7.80% |
programmed cell death involved in cell development |
GO:0060325 |
7.80% |
face morphogenesis |
GO:0050768 |
7.79% |
negative regulation of neurogenesis |
GO:0010001 |
7.73% |
glial cell differentiation |
GO:0006950 |
7.72% |
response to stress |
GO:0043010 |
7.69% |
camera-type eye development |
GO:0031018 |
7.66% |
endocrine pancreas development |
GO:0002833 |
7.63% |
positive regulation of response to biotic stimulus |
GO:0098727 |
7.61% |
maintenance of cell number |
GO:0008285 |
7.60% |
negative regulation of cell population proliferation |
GO:0051090 |
7.59% |
regulation of DNA-binding transcription factor activity |
GO:0002066 |
7.56% |
columnar/cuboidal epithelial cell development |
GO:0060021 |
7.52% |
roof of mouth development |
GO:0065009 |
7.52% |
regulation of molecular function |
GO:0007422 |
7.51% |
peripheral nervous system development |
GO:0007498 |
7.48% |
mesoderm development |
GO:0019827 |
7.47% |
stem cell population maintenance |
GO:0007346 |
7.46% |
regulation of mitotic cell cycle |
GO:0007548 |
7.44% |
sex differentiation |
GO:0045835 |
7.43% |
negative regulation of meiotic nuclear division |
GO:0022607 |
7.35% |
cellular component assembly |
GO:0042476 |
7.34% |
odontogenesis |
GO:0043900 |
7.32% |
regulation of multi-organism process |
GO:0060173 |
7.31% |
limb development |
GO:1901522 |
7.31% |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
GO:0007154 |
7.30% |
cell communication |
GO:0014706 |
7.29% |
striated muscle tissue development |
GO:0042592 |
7.28% |
homeostatic process |
GO:0051179 |
7.27% |
localization |
GO:0001764 |
7.26% |
neuron migration |
GO:0035137 |
7.26% |
hindlimb morphogenesis |
GO:0008544 |
7.24% |
epidermis development |
GO:0045931 |
7.23% |
positive regulation of mitotic cell cycle |
GO:0030335 |
7.21% |
positive regulation of cell migration |
GO:0030111 |
7.20% |
regulation of Wnt signaling pathway |
GO:0010631 |
7.19% |
epithelial cell migration |
GO:0050920 |
7.17% |
regulation of chemotaxis |
GO:0032103 |
7.17% |
positive regulation of response to external stimulus |
GO:0002684 |
7.16% |
positive regulation of immune system process |
GO:0061919 |
7.12% |
process utilizing autophagic mechanism |
GO:2000027 |
7.10% |
regulation of animal organ morphogenesis |
GO:0007517 |
7.09% |
muscle organ development |
GO:1905879 |
7.09% |
regulation of oogenesis |
GO:0036075 |
7.09% |
replacement ossification |
GO:0040014 |
7.07% |
regulation of multicellular organism growth |
GO:0001958 |
7.06% |
endochondral ossification |
GO:0030308 |
7.05% |
negative regulation of cell growth |
GO:2000178 |
6.99% |
negative regulation of neural precursor cell proliferation |
GO:0006996 |
6.98% |
organelle organization |
GO:0007492 |
6.97% |
endoderm development |
GO:0051961 |
6.97% |
negative regulation of nervous system development |
GO:0007617 |
6.97% |
mating behavior |
GO:0061448 |
6.97% |
connective tissue development |
GO:0072175 |
6.97% |
epithelial tube formation |
GO:0030278 |
6.97% |
regulation of ossification |
GO:0010634 |
6.93% |
positive regulation of epithelial cell migration |
GO:0050678 |
6.93% |
regulation of epithelial cell proliferation |
GO:2000147 |
6.91% |
positive regulation of cell motility |
GO:0033993 |
6.91% |
response to lipid |
GO:0040017 |
6.90% |
positive regulation of locomotion |
GO:0001667 |
6.86% |
ameboidal-type cell migration |
GO:0002702 |
6.85% |
positive regulation of production of molecular mediator of immune response |
GO:0050679 |
6.84% |
positive regulation of epithelial cell proliferation |
GO:0060322 |
6.84% |
head development |
GO:0120036 |
6.83% |
plasma membrane bounded cell projection organization |
GO:0021782 |
6.81% |
glial cell development |
GO:1900426 |
6.79% |
positive regulation of defense response to bacterium |
GO:0060560 |
6.78% |
developmental growth involved in morphogenesis |
GO:0014013 |
6.77% |
regulation of gliogenesis |
GO:0060179 |
6.74% |
male mating behavior |
GO:1900424 |
6.74% |
regulation of defense response to bacterium |
GO:0006914 |
6.70% |
autophagy |
GO:0032870 |
6.70% |
cellular response to hormone stimulus |
GO:0048534 |
6.69% |
hematopoietic or lymphoid organ development |
GO:0010817 |
6.69% |
regulation of hormone levels |
GO:0008589 |
6.66% |
regulation of smoothened signaling pathway |
GO:0002699 |
6.66% |
positive regulation of immune effector process |
GO:0016049 |
6.65% |
cell growth |
GO:0051272 |
6.65% |
positive regulation of cellular component movement |
GO:0032355 |
6.64% |
response to estradiol |
GO:0007297 |
6.64% |
ovarian follicle cell migration |
GO:0071772 |
6.63% |
response to BMP |
GO:0021533 |
6.63% |
cell differentiation in hindbrain |
GO:0031667 |
6.61% |
response to nutrient levels |
GO:0030858 |
6.58% |
positive regulation of epithelial cell differentiation |
GO:0048701 |
6.57% |
embryonic cranial skeleton morphogenesis |
GO:0002065 |
6.57% |
columnar/cuboidal epithelial cell differentiation |
GO:0007588 |
6.57% |
excretion |
GO:0071773 |
6.56% |
cellular response to BMP stimulus |
GO:0035112 |
6.56% |
genitalia morphogenesis |
GO:0090092 |
6.54% |
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0010639 |
6.54% |
negative regulation of organelle organization |
GO:0072009 |
6.53% |
nephron epithelium development |
GO:0051641 |
6.53% |
cellular localization |
GO:0002088 |
6.52% |
lens development in camera-type eye |
GO:0048232 |
6.49% |
male gamete generation |
GO:0030900 |
6.46% |
forebrain development |
GO:2000242 |
6.46% |
negative regulation of reproductive process |
GO:0045685 |
6.44% |
regulation of glial cell differentiation |
GO:0030177 |
6.41% |
positive regulation of Wnt signaling pathway |
GO:0006366 |
6.40% |
transcription by RNA polymerase II |
GO:0001704 |
6.36% |
formation of primary germ layer |
GO:0051234 |
6.36% |
establishment of localization |
GO:0009790 |
6.35% |
embryo development |
GO:0031016 |
6.32% |
pancreas development |
GO:0001658 |
6.28% |
branching involved in ureteric bud morphogenesis |
GO:0008584 |
6.27% |
male gonad development |
GO:0045665 |
6.25% |
negative regulation of neuron differentiation |
GO:0030097 |
6.22% |
hemopoiesis |
GO:0006810 |
6.21% |
transport |
GO:0002700 |
6.20% |
regulation of production of molecular mediator of immune response |
GO:0048839 |
6.18% |
inner ear development |
GO:0060828 |
6.16% |
regulation of canonical Wnt signaling pathway |
GO:0051784 |
6.16% |
negative regulation of nuclear division |
GO:0072073 |
6.16% |
kidney epithelium development |
GO:0021983 |
6.16% |
pituitary gland development |
GO:0040019 |
6.15% |
positive regulation of embryonic development |
GO:0048864 |
6.15% |
stem cell development |
GO:0045667 |
6.14% |
regulation of osteoblast differentiation |
GO:0008366 |
6.13% |
axon ensheathment |
GO:0070925 |
6.12% |
organelle assembly |
GO:0050954 |
6.12% |
sensory perception of mechanical stimulus |
GO:0043433 |
6.11% |
negative regulation of DNA-binding transcription factor activity |
GO:0006417 |
6.10% |
regulation of translation |
GO:0007413 |
6.09% |
axonal fasciculation |
GO:0045765 |
6.07% |
regulation of angiogenesis |
GO:0044057 |
6.07% |
regulation of system process |
GO:0009792 |
6.07% |
embryo development ending in birth or egg hatching |
GO:0045880 |
6.07% |
positive regulation of smoothened signaling pathway |
GO:0045778 |
6.05% |
positive regulation of ossification |
GO:0007283 |
6.04% |
spermatogenesis |
GO:0007416 |
6.03% |
synapse assembly |
GO:0001568 |
6.02% |
blood vessel development |
GO:0042552 |
6.02% |
myelination |
GO:0014015 |
6.01% |
positive regulation of gliogenesis |
GO:1901342 |
6.00% |
regulation of vasculature development |
GO:0051447 |
5.99% |
negative regulation of meiotic cell cycle |
GO:2000677 |
5.98% |
regulation of transcription regulatory region DNA binding |
GO:0030307 |
5.96% |
positive regulation of cell growth |
GO:0045669 |
5.96% |
positive regulation of osteoblast differentiation |
GO:0007605 |
5.93% |
sensory perception of sound |
GO:0090287 |
5.92% |
regulation of cellular response to growth factor stimulus |
GO:0061005 |
5.92% |
cell differentiation involved in kidney development |
GO:0007272 |
5.92% |
ensheathment of neurons |
GO:0045687 |
5.91% |
positive regulation of glial cell differentiation |
GO:0010608 |
5.91% |
posttranscriptional regulation of gene expression |
GO:0045840 |
5.89% |
positive regulation of mitotic nuclear division |
GO:0032330 |
5.89% |
regulation of chondrocyte differentiation |
GO:0106030 |
5.88% |
neuron projection fasciculation |
GO:0035088 |
5.88% |
establishment or maintenance of apical/basal cell polarity |
GO:0009991 |
5.86% |
response to extracellular stimulus |
GO:0007163 |
5.86% |
establishment or maintenance of cell polarity |
GO:0048857 |
5.85% |
neural nucleus development |
GO:0050953 |
5.84% |
sensory perception of light stimulus |
GO:0046620 |
5.84% |
regulation of organ growth |
GO:0048878 |
5.83% |
chemical homeostasis |
GO:0035116 |
5.83% |
embryonic hindlimb morphogenesis |
GO:0090183 |
5.82% |
regulation of kidney development |
GO:0033036 |
5.82% |
macromolecule localization |
GO:0008356 |
5.80% |
asymmetric cell division |
GO:0000902 |
5.80% |
cell morphogenesis |
GO:0099537 |
5.80% |
trans-synaptic signaling |
GO:0030878 |
5.78% |
thyroid gland development |
GO:0061035 |
5.77% |
regulation of cartilage development |
GO:0002697 |
5.76% |
regulation of immune effector process |
GO:0061245 |
5.76% |
establishment or maintenance of bipolar cell polarity |
GO:0008340 |
5.75% |
determination of adult lifespan |
GO:0090263 |
5.74% |
positive regulation of canonical Wnt signaling pathway |
GO:0060563 |
5.74% |
neuroepithelial cell differentiation |
GO:0007622 |
5.73% |
rhythmic behavior |
GO:0045184 |
5.72% |
establishment of protein localization |
GO:0006338 |
5.71% |
chromatin remodeling |
GO:0001822 |
5.71% |
kidney development |
GO:0007601 |
5.71% |
visual perception |
GO:0060688 |
5.70% |
regulation of morphogenesis of a branching structure |
GO:0042330 |
5.70% |
taxis |
GO:0040034 |
5.70% |
regulation of development, heterochronic |
GO:0050776 |
5.69% |
regulation of immune response |
GO:0031669 |
5.68% |
cellular response to nutrient levels |
GO:0042060 |
5.68% |
wound healing |
GO:0030324 |
5.64% |
lung development |
GO:0007268 |
5.64% |
chemical synaptic transmission |
GO:0023052 |
5.64% |
signaling |
GO:0048511 |
5.64% |
rhythmic process |
GO:0050778 |
5.62% |
positive regulation of immune response |
GO:0060631 |
5.62% |
regulation of meiosis I |
GO:0042733 |
5.59% |
embryonic digit morphogenesis |
GO:0048588 |
5.59% |
developmental cell growth |
GO:0090598 |
5.59% |
male anatomical structure morphogenesis |
GO:0045727 |
5.57% |
positive regulation of translation |
GO:0009611 |
5.56% |
response to wounding |
GO:0045684 |
5.56% |
positive regulation of epidermis development |
GO:0022402 |
5.56% |
cell cycle process |
GO:0048709 |
5.55% |
oligodendrocyte differentiation |
GO:0045682 |
5.54% |
regulation of epidermis development |
GO:0007169 |
5.54% |
transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0090184 |
5.53% |
positive regulation of kidney development |
GO:0051271 |
5.51% |
negative regulation of cellular component movement |
GO:0010470 |
5.51% |
regulation of gastrulation |
GO:0051101 |
5.50% |
regulation of DNA binding |
GO:2001222 |
5.50% |
regulation of neuron migration |
GO:0007088 |
5.47% |
regulation of mitotic nuclear division |
GO:0008104 |
5.47% |
protein localization |
GO:0060041 |
5.46% |
retina development in camera-type eye |
GO:0099536 |
5.45% |
synaptic signaling |
GO:0031346 |
5.44% |
positive regulation of cell projection organization |
GO:0071392 |
5.42% |
cellular response to estradiol stimulus |
GO:0035265 |
5.41% |
organ growth |
GO:0019098 |
5.41% |
reproductive behavior |
GO:0048569 |
5.39% |
post-embryonic animal organ development |
GO:0051129 |
5.38% |
negative regulation of cellular component organization |
GO:0009791 |
5.38% |
post-embryonic development |
GO:0010467 |
5.38% |
gene expression |
GO:0051054 |
5.38% |
positive regulation of DNA metabolic process |
GO:0007267 |
5.37% |
cell-cell signaling |
GO:0048585 |
5.35% |
negative regulation of response to stimulus |
GO:0008347 |
5.34% |
glial cell migration |
GO:1902692 |
5.34% |
regulation of neuroblast proliferation |
GO:0000578 |
5.34% |
embryonic axis specification |
GO:0045604 |
5.32% |
regulation of epidermal cell differentiation |
GO:1901701 |
5.31% |
cellular response to oxygen-containing compound |
GO:0098916 |
5.31% |
anterograde trans-synaptic signaling |
GO:0061217 |
5.30% |
regulation of mesonephros development |
GO:0060485 |
5.30% |
mesenchyme development |
GO:0110111 |
5.28% |
negative regulation of animal organ morphogenesis |
GO:0051098 |
5.26% |
regulation of binding |
GO:1901343 |
5.24% |
negative regulation of vasculature development |
GO:0015833 |
5.23% |
peptide transport |
GO:0007369 |
5.20% |
gastrulation |
GO:0030216 |
5.20% |
keratinocyte differentiation |
GO:0035019 |
5.20% |
somatic stem cell population maintenance |
GO:0061351 |
5.20% |
neural precursor cell proliferation |
GO:0010976 |
5.19% |
positive regulation of neuron projection development |
GO:0031668 |
5.18% |
cellular response to extracellular stimulus |
GO:0070482 |
5.17% |
response to oxygen levels |
GO:0071407 |
5.16% |
cellular response to organic cyclic compound |
GO:0050772 |
5.16% |
positive regulation of axonogenesis |
GO:0051246 |
5.14% |
regulation of protein metabolic process |
GO:0040028 |
5.12% |
regulation of vulval development |
GO:0046907 |
5.11% |
intracellular transport |
GO:0072331 |
5.09% |
signal transduction by p53 class mediator |
GO:0016331 |
5.09% |
morphogenesis of embryonic epithelium |
GO:0036293 |
5.08% |
response to decreased oxygen levels |
GO:0001889 |
5.08% |
liver development |
GO:2000181 |
5.07% |
negative regulation of blood vessel morphogenesis |
GO:2000146 |
5.07% |
negative regulation of cell motility |
GO:0044092 |
5.06% |
negative regulation of molecular function |
GO:0032268 |
5.06% |
regulation of cellular protein metabolic process |
GO:0009743 |
5.05% |
response to carbohydrate |
GO:0051049 |
5.05% |
regulation of transport |
GO:0051052 |
5.03% |
regulation of DNA metabolic process |
GO:0044093 |
5.03% |
positive regulation of molecular function |
GO:0009629 |
5.00% |
response to gravity |
GO:0045197 |
4.99% |
establishment or maintenance of epithelial cell apical/basal polarity |
GO:0034284 |
4.99% |
response to monosaccharide |
GO:0071345 |
4.98% |
cellular response to cytokine stimulus |
GO:0048713 |
4.97% |
regulation of oligodendrocyte differentiation |
GO:0048675 |
4.97% |
axon extension |
GO:0060249 |
4.95% |
anatomical structure homeostasis |
GO:0009566 |
4.94% |
fertilization |
GO:0007528 |
4.94% |
neuromuscular junction development |
GO:0002053 |
4.94% |
positive regulation of mesenchymal cell proliferation |
GO:0006261 |
4.94% |
DNA-dependent DNA replication |
GO:0009749 |
4.94% |
response to glucose |
GO:0045616 |
4.93% |
regulation of keratinocyte differentiation |
GO:0007338 |
4.92% |
single fertilization |
GO:0031175 |
4.91% |
neuron projection development |
GO:0022008 |
4.91% |
neurogenesis |
GO:0030336 |
4.91% |
negative regulation of cell migration |
GO:0042886 |
4.90% |
amide transport |
GO:0009913 |
4.90% |
epidermal cell differentiation |
GO:0006325 |
4.90% |
chromatin organization |
GO:0051050 |
4.90% |
positive regulation of transport |
GO:0042475 |
4.88% |
odontogenesis of dentin-containing tooth |
GO:0015031 |
4.88% |
protein transport |
GO:0034249 |
4.88% |
negative regulation of cellular amide metabolic process |
GO:0045773 |
4.88% |
positive regulation of axon extension |
GO:0048762 |
4.86% |
mesenchymal cell differentiation |
GO:0060479 |
4.86% |
lung cell differentiation |
GO:0048514 |
4.85% |
blood vessel morphogenesis |
GO:0080134 |
4.84% |
regulation of response to stress |
GO:0051302 |
4.83% |
regulation of cell division |
GO:0033554 |
4.83% |
cellular response to stress |
GO:0016525 |
4.82% |
negative regulation of angiogenesis |
GO:0040013 |
4.82% |
negative regulation of locomotion |
GO:0097305 |
4.81% |
response to alcohol |
GO:0017148 |
4.81% |
negative regulation of translation |
GO:0007034 |
4.80% |
vacuolar transport |
GO:1905939 |
4.79% |
regulation of gonad development |
GO:0071705 |
4.79% |
nitrogen compound transport |
GO:0035051 |
4.79% |
cardiocyte differentiation |
GO:0048582 |
4.77% |
positive regulation of post-embryonic development |
GO:0061062 |
4.77% |
regulation of nematode larval development |
GO:0034097 |
4.77% |
response to cytokine |
GO:0048536 |
4.76% |
spleen development |
GO:0006972 |
4.75% |
hyperosmotic response |
GO:0071702 |
4.75% |
organic substance transport |
GO:0009416 |
4.75% |
response to light stimulus |
GO:0110110 |
4.74% |
positive regulation of animal organ morphogenesis |
GO:0009746 |
4.74% |
response to hexose |
GO:0072091 |
4.73% |
regulation of stem cell proliferation |
GO:0021675 |
4.72% |
nerve development |
GO:0010594 |
4.71% |
regulation of endothelial cell migration |
GO:0043933 |
4.71% |
protein-containing complex subunit organization |
GO:0001666 |
4.70% |
response to hypoxia |
GO:0051493 |
4.69% |
regulation of cytoskeleton organization |
GO:0021766 |
4.69% |
hippocampus development |
GO:0032784 |
4.68% |
regulation of DNA-templated transcription, elongation |
GO:0071496 |
4.68% |
cellular response to external stimulus |
GO:0016050 |
4.68% |
vesicle organization |
GO:0001894 |
4.67% |
tissue homeostasis |
GO:0009314 |
4.64% |
response to radiation |
GO:0021537 |
4.63% |
telencephalon development |
GO:0070727 |
4.63% |
cellular macromolecule localization |
GO:0060341 |
4.62% |
regulation of cellular localization |
GO:0042538 |
4.62% |
hyperosmotic salinity response |
GO:0030510 |
4.62% |
regulation of BMP signaling pathway |
GO:2000736 |
4.61% |
regulation of stem cell differentiation |
GO:0051169 |
4.61% |
nuclear transport |
GO:0044782 |
4.60% |
cilium organization |
GO:0003044 |
4.59% |
regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0007219 |
4.59% |
Notch signaling pathway |
GO:0006913 |
4.58% |
nucleocytoplasmic transport |
GO:1903706 |
4.58% |
regulation of hemopoiesis |
GO:0001990 |
4.58% |
regulation of systemic arterial blood pressure by hormone |
GO:0042752 |
4.58% |
regulation of circadian rhythm |
GO:0050773 |
4.57% |
regulation of dendrite development |
GO:0031670 |
4.57% |
cellular response to nutrient |
GO:0050795 |
4.57% |
regulation of behavior |
GO:0045599 |
4.56% |
negative regulation of fat cell differentiation |
GO:0008543 |
4.56% |
fibroblast growth factor receptor signaling pathway |
GO:0032880 |
4.56% |
regulation of protein localization |
GO:2000179 |
4.56% |
positive regulation of neural precursor cell proliferation |
GO:0002683 |
4.54% |
negative regulation of immune system process |
GO:0071396 |
4.54% |
cellular response to lipid |
GO:0042445 |
4.54% |
hormone metabolic process |
GO:0060047 |
4.54% |
heart contraction |
GO:0034622 |
4.53% |
cellular protein-containing complex assembly |
GO:0016055 |
4.52% |
Wnt signaling pathway |
GO:0048753 |
4.52% |
pigment granule organization |
GO:0008585 |
4.52% |
female gonad development |
GO:0048469 |
4.50% |
cell maturation |
GO:0048844 |
4.49% |
artery morphogenesis |
GO:1901880 |
4.49% |
negative regulation of protein depolymerization |
GO:0002376 |
4.48% |
immune system process |
GO:0006333 |
4.48% |
chromatin assembly or disassembly |
GO:0021545 |
4.48% |
cranial nerve development |
GO:0021515 |
4.48% |
cell differentiation in spinal cord |
GO:0044255 |
4.46% |
cellular lipid metabolic process |
GO:0048871 |
4.46% |
multicellular organismal homeostasis |
GO:0044087 |
4.45% |
regulation of cellular component biogenesis |
GO:0090087 |
4.45% |
regulation of peptide transport |
GO:0050878 |
4.45% |
regulation of body fluid levels |
GO:0071695 |
4.44% |
anatomical structure maturation |
GO:0008582 |
4.43% |
regulation of synaptic growth at neuromuscular junction |
GO:0010810 |
4.42% |
regulation of cell-substrate adhesion |
GO:0010464 |
4.40% |
regulation of mesenchymal cell proliferation |
GO:0006886 |
4.40% |
intracellular protein transport |
GO:0090100 |
4.39% |
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0006260 |
4.39% |
DNA replication |
GO:1905330 |
4.38% |
regulation of morphogenesis of an epithelium |
GO:0051099 |
4.38% |
positive regulation of binding |
GO:1905114 |
4.38% |
cell surface receptor signaling pathway involved in cell-cell signaling |
GO:1901654 |
4.37% |
response to ketone |
GO:1904396 |
4.36% |
regulation of neuromuscular junction development |
GO:1990138 |
4.34% |
neuron projection extension |
GO:0071824 |
4.34% |
protein-DNA complex subunit organization |
GO:1903708 |
4.34% |
positive regulation of hemopoiesis |
GO:0001952 |
4.32% |
regulation of cell-matrix adhesion |
GO:0009639 |
4.32% |
response to red or far red light |
GO:0046622 |
4.32% |
positive regulation of organ growth |
GO:0001837 |
4.31% |
epithelial to mesenchymal transition |
GO:0065004 |
4.31% |
protein-DNA complex assembly |
GO:0031347 |
4.30% |
regulation of defense response |
GO:0001656 |
4.30% |
metanephros development |
GO:0071684 |
4.29% |
organism emergence from protective structure |
GO:0030011 |
4.28% |
maintenance of cell polarity |
GO:0048512 |
4.28% |
circadian behavior |
GO:0009855 |
4.28% |
determination of bilateral symmetry |
GO:0009968 |
4.26% |
negative regulation of signal transduction |
GO:0003013 |
4.26% |
circulatory system process |
GO:0048706 |
4.26% |
embryonic skeletal system development |
GO:0007623 |
4.26% |
circadian rhythm |
GO:0048640 |
4.26% |
negative regulation of developmental growth |
GO:0007368 |
4.26% |
determination of left/right symmetry |
GO:0044786 |
4.25% |
cell cycle DNA replication |
GO:0043535 |
4.24% |
regulation of blood vessel endothelial cell migration |
GO:0050808 |
4.24% |
synapse organization |
GO:0050886 |
4.22% |
endocrine process |
GO:0048814 |
4.22% |
regulation of dendrite morphogenesis |
GO:0043388 |
4.22% |
positive regulation of DNA binding |
GO:0032269 |
4.20% |
negative regulation of cellular protein metabolic process |
GO:0070201 |
4.20% |
regulation of establishment of protein localization |
GO:0033365 |
4.20% |
protein localization to organelle |
GO:0033044 |
4.20% |
regulation of chromosome organization |
GO:0032968 |
4.19% |
positive regulation of transcription elongation from RNA polymerase II promoter |
GO:1901879 |
4.19% |
regulation of protein depolymerization |
GO:0007584 |
4.19% |
response to nutrient |
GO:0043207 |
4.19% |
response to external biotic stimulus |
GO:1903859 |
4.19% |
regulation of dendrite extension |
GO:0055001 |
4.18% |
muscle cell development |
GO:0045475 |
4.18% |
locomotor rhythm |
GO:0006644 |
4.16% |
phospholipid metabolic process |
GO:0001890 |
4.15% |
placenta development |
GO:0048103 |
4.14% |
somatic stem cell division |
GO:0009826 |
4.14% |
unidimensional cell growth |
GO:0060612 |
4.13% |
adipose tissue development |
GO:0007586 |
4.13% |
digestion |
GO:0042593 |
4.12% |
glucose homeostasis |
GO:0035556 |
4.12% |
intracellular signal transduction |
GO:0030857 |
4.12% |
negative regulation of epithelial cell differentiation |
GO:0035050 |
4.11% |
embryonic heart tube development |
GO:0042692 |
4.09% |
muscle cell differentiation |
GO:0045598 |
4.08% |
regulation of fat cell differentiation |
GO:0051248 |
4.08% |
negative regulation of protein metabolic process |
GO:0033500 |
4.07% |
carbohydrate homeostasis |
GO:0010648 |
4.07% |
negative regulation of cell communication |
GO:0072332 |
4.06% |
intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0034243 |
4.06% |
regulation of transcription elongation from RNA polymerase II promoter |
GO:0048872 |
4.06% |
homeostasis of number of cells |
GO:0007606 |
4.05% |
sensory perception of chemical stimulus |
GO:0060070 |
4.05% |
canonical Wnt signaling pathway |
GO:0090066 |
4.05% |
regulation of anatomical structure size |
GO:0065003 |
4.05% |
protein-containing complex assembly |
GO:0051223 |
4.04% |
regulation of protein transport |
GO:1903861 |
4.04% |
positive regulation of dendrite extension |
GO:0097193 |
4.02% |
intrinsic apoptotic signaling pathway |
GO:0060271 |
4.02% |
cilium assembly |
GO:0009799 |
4.01% |
specification of symmetry |
GO:1902275 |
4.01% |
regulation of chromatin organization |
GO:0031114 |
4.01% |
regulation of microtubule depolymerization |
GO:0023057 |
4.01% |
negative regulation of signaling |
GO:0008016 |
3.99% |
regulation of heart contraction |
GO:0045639 |
3.99% |
positive regulation of myeloid cell differentiation |
GO:1901989 |
3.99% |
positive regulation of cell cycle phase transition |
GO:0097306 |
3.98% |
cellular response to alcohol |
GO:1901987 |
3.97% |
regulation of cell cycle phase transition |
GO:0060411 |
3.97% |
cardiac septum morphogenesis |
GO:0010717 |
3.97% |
regulation of epithelial to mesenchymal transition |
GO:0030879 |
3.97% |
mammary gland development |
GO:2000679 |
3.96% |
positive regulation of transcription regulatory region DNA binding |
GO:0051963 |
3.95% |
regulation of synapse assembly |
GO:0021700 |
3.95% |
developmental maturation |
GO:0002164 |
3.93% |
larval development |
GO:0034613 |
3.93% |
cellular protein localization |
GO:0010171 |
3.93% |
body morphogenesis |
GO:0032925 |
3.93% |
regulation of activin receptor signaling pathway |
GO:0009636 |
3.91% |
response to toxic substance |
GO:0090049 |
3.91% |
regulation of cell migration involved in sprouting angiogenesis |
GO:0031507 |
3.91% |
heterochromatin assembly |
GO:0097190 |
3.90% |
apoptotic signaling pathway |
GO:0010948 |
3.90% |
negative regulation of cell cycle process |
GO:0002067 |
3.90% |
glandular epithelial cell differentiation |
GO:0044089 |
3.88% |
positive regulation of cellular component biogenesis |
GO:0031099 |
3.88% |
regeneration |
GO:0032886 |
3.87% |
regulation of microtubule-based process |
GO:0044062 |
3.87% |
regulation of excretion |
GO:0007049 |
3.86% |
cell cycle |
GO:0007010 |
3.85% |
cytoskeleton organization |
GO:0044319 |
3.85% |
wound healing, spreading of cells |
GO:0043392 |
3.84% |
negative regulation of DNA binding |
GO:0000904 |
3.83% |
cell morphogenesis involved in differentiation |
GO:0051168 |
3.83% |
nuclear export |
GO:0009607 |
3.83% |
response to biotic stimulus |
GO:0060606 |
3.82% |
tube closure |
GO:0071453 |
3.82% |
cellular response to oxygen levels |
GO:1901992 |
3.82% |
positive regulation of mitotic cell cycle phase transition |
GO:0007026 |
3.81% |
negative regulation of microtubule depolymerization |
GO:0035162 |
3.80% |
embryonic hemopoiesis |
GO:0046903 |
3.80% |
secretion |
GO:0046879 |
3.79% |
hormone secretion |
GO:0031110 |
3.78% |
regulation of microtubule polymerization or depolymerization |
GO:0070828 |
3.77% |
heterochromatin organization |
GO:0008593 |
3.77% |
regulation of Notch signaling pathway |
GO:0043242 |
3.77% |
negative regulation of protein complex disassembly |
GO:0038127 |
3.76% |
ERBB signaling pathway |
GO:0031056 |
3.76% |
regulation of histone modification |
GO:0043525 |
3.75% |
positive regulation of neuron apoptotic process |
GO:0021987 |
3.75% |
cerebral cortex development |
GO:0031349 |
3.75% |
positive regulation of defense response |
GO:0045637 |
3.74% |
regulation of myeloid cell differentiation |
GO:0070507 |
3.74% |
regulation of microtubule cytoskeleton organization |
GO:1901216 |
3.72% |
positive regulation of neuron death |
GO:0044248 |
3.72% |
cellular catabolic process |
GO:0000278 |
3.72% |
mitotic cell cycle |
GO:0030155 |
3.72% |
regulation of cell adhesion |
GO:0048841 |
3.72% |
regulation of axon extension involved in axon guidance |
GO:1903034 |
3.72% |
regulation of response to wounding |
GO:0010971 |
3.72% |
positive regulation of G2/M transition of mitotic cell cycle |
GO:0043537 |
3.71% |
negative regulation of blood vessel endothelial cell migration |
GO:0051091 |
3.71% |
positive regulation of DNA-binding transcription factor activity |
GO:1990830 |
3.71% |
cellular response to leukemia inhibitory factor |
GO:0034504 |
3.71% |
protein localization to nucleus |
GO:0045786 |
3.70% |
negative regulation of cell cycle |
GO:0110148 |
3.70% |
biomineralization |
GO:0002027 |
3.69% |
regulation of heart rate |
GO:0031497 |
3.68% |
chromatin assembly |
GO:0031214 |
3.68% |
biomineral tissue development |
GO:0030031 |
3.68% |
cell projection assembly |
GO:0045646 |
3.67% |
regulation of erythrocyte differentiation |
GO:0031111 |
3.67% |
negative regulation of microtubule polymerization or depolymerization |
GO:0009914 |
3.67% |
hormone transport |
GO:0001843 |
3.66% |
neural tube closure |
GO:0045187 |
3.66% |
regulation of circadian sleep/wake cycle, sleep |
GO:0048048 |
3.65% |
embryonic eye morphogenesis |
GO:0001755 |
3.65% |
neural crest cell migration |
GO:0014014 |
3.64% |
negative regulation of gliogenesis |
GO:0050673 |
3.64% |
epithelial cell proliferation |
GO:1905268 |
3.63% |
negative regulation of chromatin organization |
GO:0048580 |
3.63% |
regulation of post-embryonic development |
GO:0010927 |
3.63% |
cellular component assembly involved in morphogenesis |
GO:0120031 |
3.62% |
plasma membrane bounded cell projection assembly |
GO:0010842 |
3.60% |
retina layer formation |
GO:1990823 |
3.60% |
response to leukemia inhibitory factor |
GO:0042753 |
3.60% |
positive regulation of circadian rhythm |
GO:0016192 |
3.60% |
vesicle-mediated transport |
GO:0035065 |
3.59% |
regulation of histone acetylation |
GO:0006935 |
3.58% |
chemotaxis |
GO:0048520 |
3.58% |
positive regulation of behavior |
GO:0030513 |
3.57% |
positive regulation of BMP signaling pathway |
GO:0072163 |
3.57% |
mesonephric epithelium development |
GO:2000756 |
3.56% |
regulation of peptidyl-lysine acetylation |
GO:1903522 |
3.55% |
regulation of blood circulation |
GO:0032786 |
3.55% |
positive regulation of DNA-templated transcription, elongation |
GO:1902895 |
3.54% |
positive regulation of pri-miRNA transcription by RNA polymerase II |
GO:0010595 |
3.54% |
positive regulation of endothelial cell migration |
GO:0001525 |
3.53% |
angiogenesis |
GO:0006629 |
3.53% |
lipid metabolic process |
GO:1903047 |
3.53% |
mitotic cell cycle process |
GO:0042594 |
3.52% |
response to starvation |
GO:0030325 |
3.52% |
adrenal gland development |
GO:0022610 |
3.51% |
biological adhesion |
GO:0007632 |
3.51% |
visual behavior |
GO:0050764 |
3.50% |
regulation of phagocytosis |
GO:0031057 |
3.50% |
negative regulation of histone modification |
GO:0009755 |
3.50% |
hormone-mediated signaling pathway |
GO:0017145 |
3.50% |
stem cell division |
GO:0061041 |
3.50% |
regulation of wound healing |
GO:0019725 |
3.50% |
cellular homeostasis |
GO:0032940 |
3.48% |
secretion by cell |
GO:0007173 |
3.47% |
epidermal growth factor receptor signaling pathway |
GO:0007635 |
3.45% |
chemosensory behavior |
GO:0051046 |
3.44% |
regulation of secretion |
GO:0001838 |
3.43% |
embryonic epithelial tube formation |
GO:0003151 |
3.43% |
outflow tract morphogenesis |
GO:0051707 |
3.42% |
response to other organism |
GO:0050807 |
3.42% |
regulation of synapse organization |
GO:0072164 |
3.41% |
mesonephric tubule development |
GO:0051100 |
3.41% |
negative regulation of binding |
GO:0051146 |
3.39% |
striated muscle cell differentiation |
GO:0035809 |
3.39% |
regulation of urine volume |
GO:0051494 |
3.38% |
negative regulation of cytoskeleton organization |
GO:0042634 |
3.38% |
regulation of hair cycle |
GO:0003015 |
3.38% |
heart process |
GO:0007164 |
3.37% |
establishment of tissue polarity |
GO:0051897 |
3.37% |
positive regulation of protein kinase B signaling |
GO:0032107 |
3.37% |
regulation of response to nutrient levels |
GO:0048532 |
3.37% |
anatomical structure arrangement |
GO:0051145 |
3.36% |
smooth muscle cell differentiation |
GO:0007155 |
3.35% |
cell adhesion |
GO:0140352 |
3.34% |
export from cell |
GO:0097150 |
3.34% |
neuronal stem cell population maintenance |
GO:0055065 |
3.34% |
metal ion homeostasis |
GO:0050775 |
3.33% |
positive regulation of dendrite morphogenesis |
GO:0022404 |
3.33% |
molting cycle process |
GO:0045746 |
3.33% |
negative regulation of Notch signaling pathway |
GO:0009056 |
3.33% |
catabolic process |
GO:0072594 |
3.33% |
establishment of protein localization to organelle |
GO:0046621 |
3.33% |
negative regulation of organ growth |
GO:0010719 |
3.33% |
negative regulation of epithelial to mesenchymal transition |
GO:0019637 |
3.33% |
organophosphate metabolic process |
GO:0050821 |
3.32% |
protein stabilization |
GO:0001707 |
3.31% |
mesoderm formation |
GO:0002791 |
3.30% |
regulation of peptide secretion |
GO:0060317 |
3.30% |
cardiac epithelial to mesenchymal transition |
GO:1901983 |
3.30% |
regulation of protein acetylation |
GO:1902751 |
3.30% |
positive regulation of cell cycle G2/M phase transition |
GO:0050905 |
3.30% |
neuromuscular process |
GO:2001251 |
3.30% |
negative regulation of chromosome organization |
GO:0048286 |
3.30% |
lung alveolus development |
GO:0006970 |
3.29% |
response to osmotic stress |
GO:0002052 |
3.29% |
positive regulation of neuroblast proliferation |
GO:0042246 |
3.27% |
tissue regeneration |
GO:0090659 |
3.26% |
walking behavior |
GO:0090101 |
3.26% |
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0016358 |
3.26% |
dendrite development |
GO:0035914 |
3.26% |
skeletal muscle cell differentiation |
GO:1901564 |
3.26% |
organonitrogen compound metabolic process |
GO:0045766 |
3.25% |
positive regulation of angiogenesis |
GO:0036294 |
3.25% |
cellular response to decreased oxygen levels |
GO:0007568 |
3.24% |
aging |
GO:0032104 |
3.23% |
regulation of response to extracellular stimulus |
GO:0035094 |
3.23% |
response to nicotine |
GO:0048634 |
3.23% |
regulation of muscle organ development |
GO:0098743 |
3.23% |
cell aggregation |
GO:0098771 |
3.22% |
inorganic ion homeostasis |
GO:0005996 |
3.21% |
monosaccharide metabolic process |
GO:0045471 |
3.21% |
response to ethanol |
GO:0034698 |
3.21% |
response to gonadotropin |
GO:0009651 |
3.21% |
response to salt stress |
GO:0032350 |
3.21% |
regulation of hormone metabolic process |
GO:0062012 |
3.21% |
regulation of small molecule metabolic process |
GO:0001659 |
3.20% |
temperature homeostasis |
GO:0032535 |
3.20% |
regulation of cellular component size |
GO:0030512 |
3.19% |
negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0042059 |
3.19% |
negative regulation of epidermal growth factor receptor signaling pathway |
GO:0051170 |
3.18% |
import into nucleus |
GO:0090276 |
3.18% |
regulation of peptide hormone secretion |
GO:0002763 |
3.17% |
positive regulation of myeloid leukocyte differentiation |
GO:1903845 |
3.17% |
negative regulation of cellular response to transforming growth factor beta stimulus |
GO:0036314 |
3.17% |
response to sterol |
GO:0009612 |
3.16% |
response to mechanical stimulus |
GO:0019218 |
3.16% |
regulation of steroid metabolic process |
GO:0050891 |
3.16% |
multicellular organismal water homeostasis |
GO:0030036 |
3.15% |
actin cytoskeleton organization |
GO:0045879 |
3.15% |
negative regulation of smoothened signaling pathway |
GO:0030104 |
3.14% |
water homeostasis |
GO:0071692 |
3.14% |
protein localization to extracellular region |
GO:0046686 |
3.14% |
response to cadmium ion |
GO:0007628 |
3.14% |
adult walking behavior |
GO:0044281 |
3.13% |
small molecule metabolic process |
GO:0045444 |
3.13% |
fat cell differentiation |
GO:0060840 |
3.10% |
artery development |
GO:0032352 |
3.10% |
positive regulation of hormone metabolic process |
GO:0007059 |
3.10% |
chromosome segregation |
GO:1901185 |
3.10% |
negative regulation of ERBB signaling pathway |
GO:0006796 |
3.09% |
phosphate-containing compound metabolic process |
GO:0045638 |
3.09% |
negative regulation of myeloid cell differentiation |
GO:1903530 |
3.09% |
regulation of secretion by cell |
GO:0006793 |
3.08% |
phosphorus metabolic process |
GO:0048168 |
3.08% |
regulation of neuronal synaptic plasticity |
GO:0044703 |
3.08% |
multi-organism reproductive process |
GO:0019318 |
3.08% |
hexose metabolic process |
GO:0048854 |
3.08% |
brain morphogenesis |
GO:0048738 |
3.07% |
cardiac muscle tissue development |
GO:0044030 |
3.07% |
regulation of DNA methylation |
GO:0055080 |
3.06% |
cation homeostasis |
GO:0045814 |
3.06% |
negative regulation of gene expression, epigenetic |
GO:0000226 |
3.05% |
microtubule cytoskeleton organization |
GO:0042440 |
3.05% |
pigment metabolic process |
GO:0030178 |
3.05% |
negative regulation of Wnt signaling pathway |
GO:0043244 |
3.05% |
regulation of protein complex disassembly |
GO:1903671 |
3.05% |
negative regulation of sprouting angiogenesis |
GO:0099402 |
3.05% |
plant organ development |
GO:0001736 |
3.05% |
establishment of planar polarity |
GO:0090288 |
3.04% |
negative regulation of cellular response to growth factor stimulus |
GO:0009649 |
3.04% |
entrainment of circadian clock |
GO:0060260 |
3.04% |
regulation of transcription initiation from RNA polymerase II promoter |
GO:1902107 |
3.04% |
positive regulation of leukocyte differentiation |
GO:0035904 |
3.03% |
aorta development |
GO:0040029 |
3.03% |
regulation of gene expression, epigenetic |
GO:0035592 |
3.02% |
establishment of protein localization to extracellular region |
GO:0055075 |
3.02% |
potassium ion homeostasis |
GO:0006611 |
3.02% |
protein export from nucleus |
GO:0043009 |
3.02% |
chordate embryonic development |
GO:0003073 |
3.01% |
regulation of systemic arterial blood pressure |
GO:0002244 |
3.01% |
hematopoietic progenitor cell differentiation |
GO:0046883 |
3.01% |
regulation of hormone secretion |
GO:0030522 |
3.00% |
intracellular receptor signaling pathway |
GO:1904018 |
3.00% |
positive regulation of vasculature development |
GO:0043536 |
3.00% |
positive regulation of blood vessel endothelial cell migration |
GO:1902850 |
3.00% |
microtubule cytoskeleton organization involved in mitosis |
GO:0003382 |
2.99% |
epithelial cell morphogenesis |
GO:0030073 |
2.98% |
insulin secretion |
GO:1902903 |
2.98% |
regulation of supramolecular fiber organization |
GO:0047484 |
2.98% |
regulation of response to osmotic stress |
GO:0001569 |
2.97% |
branching involved in blood vessel morphogenesis |
GO:1902105 |
2.96% |
regulation of leukocyte differentiation |
GO:0030183 |
2.96% |
B cell differentiation |
GO:0010633 |
2.96% |
negative regulation of epithelial cell migration |
GO:0009850 |
2.96% |
auxin metabolic process |
GO:0097435 |
2.95% |
supramolecular fiber organization |
GO:0045747 |
2.95% |
positive regulation of Notch signaling pathway |
GO:0071371 |
2.95% |
cellular response to gonadotropin stimulus |
GO:0023061 |
2.94% |
signal release |
GO:0034728 |
2.94% |
nucleosome organization |
GO:0055082 |
2.93% |
cellular chemical homeostasis |
GO:0043270 |
2.93% |
positive regulation of ion transport |
GO:1903827 |
2.93% |
regulation of cellular protein localization |
GO:1902074 |
2.93% |
response to salt |
GO:0006403 |
2.93% |
RNA localization |
GO:0001570 |
2.93% |
vasculogenesis |
GO:0003156 |
2.92% |
regulation of animal organ formation |
GO:0006352 |
2.91% |
DNA-templated transcription, initiation |
GO:0050708 |
2.91% |
regulation of protein secretion |
GO:0060261 |
2.90% |
positive regulation of transcription initiation from RNA polymerase II promoter |
GO:0043153 |
2.90% |
entrainment of circadian clock by photoperiod |
GO:0051247 |
2.90% |
positive regulation of protein metabolic process |
GO:0030072 |
2.89% |
peptide hormone secretion |
GO:0042446 |
2.89% |
hormone biosynthetic process |
GO:0010596 |
2.89% |
negative regulation of endothelial cell migration |
GO:0007585 |
2.89% |
respiratory gaseous exchange by respiratory system |
GO:0030101 |
2.89% |
natural killer cell activation |
GO:0050909 |
2.88% |
sensory perception of taste |
GO:0009733 |
2.88% |
response to auxin |
GO:0030029 |
2.88% |
actin filament-based process |
GO:0006353 |
2.87% |
DNA-templated transcription, termination |
GO:0031399 |
2.87% |
regulation of protein modification process |
GO:0045214 |
2.86% |
sarcomere organization |
GO:0051047 |
2.86% |
positive regulation of secretion |
GO:0001701 |
2.86% |
in utero embryonic development |
GO:0022405 |
2.86% |
hair cycle process |
GO:0014812 |
2.85% |
muscle cell migration |
GO:0023014 |
2.85% |
signal transduction by protein phosphorylation |
GO:0051276 |
2.84% |
chromosome organization |
GO:0006873 |
2.83% |
cellular ion homeostasis |
GO:0072507 |
2.83% |
divalent inorganic cation homeostasis |
GO:0007349 |
2.83% |
cellularization |
GO:0002793 |
2.83% |
positive regulation of peptide secretion |
GO:0009267 |
2.83% |
cellular response to starvation |
GO:1904019 |
2.83% |
epithelial cell apoptotic process |
GO:0043114 |
2.82% |
regulation of vascular permeability |
GO:0009648 |
2.82% |
photoperiodism |
GO:1901862 |
2.82% |
negative regulation of muscle tissue development |
GO:1900006 |
2.82% |
positive regulation of dendrite development |
GO:0008286 |
2.81% |
insulin receptor signaling pathway |
GO:0055006 |
2.81% |
cardiac cell development |
GO:0030003 |
2.81% |
cellular cation homeostasis |
GO:0003007 |
2.81% |
heart morphogenesis |
GO:0032868 |
2.81% |
response to insulin |
GO:0055083 |
2.80% |
monovalent inorganic anion homeostasis |
GO:0045662 |
2.80% |
negative regulation of myoblast differentiation |
GO:0007041 |
2.80% |
lysosomal transport |
GO:0007274 |
2.80% |
neuromuscular synaptic transmission |
GO:0006875 |
2.79% |
cellular metal ion homeostasis |
GO:1905207 |
2.79% |
regulation of cardiocyte differentiation |
GO:0071456 |
2.79% |
cellular response to hypoxia |
GO:0044344 |
2.79% |
cellular response to fibroblast growth factor stimulus |
GO:1903707 |
2.79% |
negative regulation of hemopoiesis |
GO:0060415 |
2.79% |
muscle tissue morphogenesis |
GO:0032970 |
2.78% |
regulation of actin filament-based process |
GO:0055007 |
2.78% |
cardiac muscle cell differentiation |
GO:0008333 |
2.77% |
endosome to lysosome transport |
GO:0009306 |
2.77% |
protein secretion |
GO:0030198 |
2.77% |
extracellular matrix organization |
GO:2001020 |
2.76% |
regulation of response to DNA damage stimulus |
GO:0060966 |
2.76% |
regulation of gene silencing by RNA |
GO:0007286 |
2.76% |
spermatid development |
GO:0010506 |
2.76% |
regulation of autophagy |
GO:2000648 |
2.76% |
positive regulation of stem cell proliferation |
GO:0007017 |
2.75% |
microtubule-based process |
GO:0002119 |
2.75% |
nematode larval development |
GO:0070647 |
2.75% |
protein modification by small protein conjugation or removal |
GO:0050796 |
2.74% |
regulation of insulin secretion |
GO:1903844 |
2.74% |
regulation of cellular response to transforming growth factor beta stimulus |
GO:0010771 |
2.74% |
negative regulation of cell morphogenesis involved in differentiation |
GO:0042048 |
2.74% |
olfactory behavior |
GO:0032386 |
2.74% |
regulation of intracellular transport |
GO:0003014 |
2.73% |
renal system process |
GO:1902893 |
2.72% |
regulation of pri-miRNA transcription by RNA polymerase II |
GO:0000165 |
2.72% |
MAPK cascade |
GO:0001657 |
2.72% |
ureteric bud development |
GO:1900046 |
2.71% |
regulation of hemostasis |
GO:0032446 |
2.71% |
protein modification by small protein conjugation |
GO:1903670 |
2.71% |
regulation of sprouting angiogenesis |
GO:0031329 |
2.70% |
regulation of cellular catabolic process |
GO:0008380 |
2.70% |
RNA splicing |
GO:0009950 |
2.69% |
dorsal/ventral axis specification |
GO:0055013 |
2.69% |
cardiac muscle cell development |
GO:0009411 |
2.69% |
response to UV |
GO:0031644 |
2.69% |
regulation of nervous system process |
GO:0031647 |
2.68% |
regulation of protein stability |
GO:1904893 |
2.68% |
negative regulation of receptor signaling pathway via STAT |
GO:0019538 |
2.68% |
protein metabolic process |
GO:0071774 |
2.68% |
response to fibroblast growth factor |
GO:0060004 |
2.66% |
reflex |
GO:0090090 |
2.65% |
negative regulation of canonical Wnt signaling pathway |
GO:0002761 |
2.65% |
regulation of myeloid leukocyte differentiation |
GO:0051017 |
2.64% |
actin filament bundle assembly |
GO:0022411 |
2.64% |
cellular component disassembly |
GO:0043062 |
2.64% |
extracellular structure organization |
GO:1902904 |
2.63% |
negative regulation of supramolecular fiber organization |
GO:0006952 |
2.62% |
defense response |
GO:0009896 |
2.62% |
positive regulation of catabolic process |
GO:0017015 |
2.62% |
regulation of transforming growth factor beta receptor signaling pathway |
GO:0045672 |
2.61% |
positive regulation of osteoclast differentiation |
GO:0034764 |
2.61% |
positive regulation of transmembrane transport |
GO:0006974 |
2.61% |
cellular response to DNA damage stimulus |
GO:1901990 |
2.61% |
regulation of mitotic cell cycle phase transition |
GO:2000142 |
2.61% |
regulation of DNA-templated transcription, initiation |
GO:0061564 |
2.61% |
axon development |
GO:0046677 |
2.61% |
response to antibiotic |
GO:0050900 |
2.61% |
leukocyte migration |
GO:0032270 |
2.60% |
positive regulation of cellular protein metabolic process |
GO:0043412 |
2.60% |
macromolecule modification |
GO:0010827 |
2.60% |
regulation of glucose transmembrane transport |
GO:0071333 |
2.60% |
cellular response to glucose stimulus |
GO:0048013 |
2.60% |
ephrin receptor signaling pathway |
GO:0001101 |
2.60% |
response to acid chemical |
GO:0002790 |
2.60% |
peptide secretion |
GO:0009266 |
2.60% |
response to temperature stimulus |
GO:0046716 |
2.60% |
muscle cell cellular homeostasis |
GO:0034329 |
2.60% |
cell junction assembly |
GO:0034724 |
2.59% |
DNA replication-independent nucleosome organization |
GO:0006275 |
2.59% |
regulation of DNA replication |
GO:0071326 |
2.59% |
cellular response to monosaccharide stimulus |
GO:0051053 |
2.58% |
negative regulation of DNA metabolic process |
GO:0099177 |
2.58% |
regulation of trans-synaptic signaling |
GO:1903532 |
2.58% |
positive regulation of secretion by cell |
GO:0007614 |
2.57% |
short-term memory |
GO:0010661 |
2.57% |
positive regulation of muscle cell apoptotic process |
GO:0006336 |
2.56% |
DNA replication-independent nucleosome assembly |
GO:0060421 |
2.56% |
positive regulation of heart growth |
GO:0006109 |
2.56% |
regulation of carbohydrate metabolic process |
GO:0055008 |
2.56% |
cardiac muscle tissue morphogenesis |
GO:0051222 |
2.56% |
positive regulation of protein transport |
GO:0033574 |
2.56% |
response to testosterone |
GO:0031032 |
2.56% |
actomyosin structure organization |
GO:0072089 |
2.56% |
stem cell proliferation |
GO:0006006 |
2.56% |
glucose metabolic process |
GO:0030098 |
2.56% |
lymphocyte differentiation |
GO:0010038 |
2.55% |
response to metal ion |
GO:0005975 |
2.55% |
carbohydrate metabolic process |
GO:0001947 |
2.55% |
heart looping |
GO:0043627 |
2.55% |
response to estrogen |
GO:0070920 |
2.54% |
regulation of production of small RNA involved in gene silencing by RNA |
GO:0034330 |
2.54% |
cell junction organization |
GO:1901888 |
2.54% |
regulation of cell junction assembly |
GO:1903311 |
2.54% |
regulation of mRNA metabolic process |
GO:0090277 |
2.53% |
positive regulation of peptide hormone secretion |
GO:0045686 |
2.53% |
negative regulation of glial cell differentiation |
GO:0034762 |
2.53% |
regulation of transmembrane transport |
GO:0051147 |
2.53% |
regulation of muscle cell differentiation |
GO:1904951 |
2.53% |
positive regulation of establishment of protein localization |
GO:1903798 |
2.53% |
regulation of production of miRNAs involved in gene silencing by miRNA |
GO:0060147 |
2.52% |
regulation of posttranscriptional gene silencing |
GO:0048831 |
2.52% |
regulation of shoot system development |
GO:0090102 |
2.52% |
cochlea development |
GO:0043254 |
2.52% |
regulation of protein complex assembly |
GO:0071241 |
2.52% |
cellular response to inorganic substance |
GO:0071322 |
2.52% |
cellular response to carbohydrate stimulus |
GO:2001023 |
2.52% |
regulation of response to drug |
GO:0001938 |
2.52% |
positive regulation of endothelial cell proliferation |
GO:0019748 |
2.51% |
secondary metabolic process |
GO:0070897 |
2.50% |
transcription preinitiation complex assembly |
GO:0018205 |
2.50% |
peptidyl-lysine modification |
GO:0021522 |
2.50% |
spinal cord motor neuron differentiation |
GO:0009555 |
2.50% |
pollen development |
GO:0046324 |
2.49% |
regulation of glucose import |
GO:0030217 |
2.49% |
T cell differentiation |
GO:0048635 |
2.49% |
negative regulation of muscle organ development |
GO:0044267 |
2.49% |
cellular protein metabolic process |
GO:0070570 |
2.49% |
regulation of neuron projection regeneration |
GO:0008298 |
2.48% |
intracellular mRNA localization |
GO:0043588 |
2.48% |
skin development |
GO:0055002 |
2.48% |
striated muscle cell development |
GO:0071103 |
2.47% |
DNA conformation change |
GO:0098609 |
2.47% |
cell-cell adhesion |
GO:0071248 |
2.47% |
cellular response to metal ion |
GO:1901861 |
2.47% |
regulation of muscle tissue development |
GO:0045058 |
2.47% |
T cell selection |
GO:0030099 |
2.46% |
myeloid cell differentiation |
GO:0010035 |
2.46% |
response to inorganic substance |
GO:0060627 |
2.46% |
regulation of vesicle-mediated transport |
GO:0071711 |
2.46% |
basement membrane organization |
GO:0042074 |
2.45% |
cell migration involved in gastrulation |
GO:0050801 |
2.45% |
ion homeostasis |
GO:0040036 |
2.45% |
regulation of fibroblast growth factor receptor signaling pathway |
GO:0010718 |
2.45% |
positive regulation of epithelial to mesenchymal transition |
GO:0046649 |
2.45% |
lymphocyte activation |
GO:0008306 |
2.44% |
associative learning |
GO:1905952 |
2.44% |
regulation of lipid localization |
GO:2000144 |
2.43% |
positive regulation of DNA-templated transcription, initiation |
GO:0009894 |
2.43% |
regulation of catabolic process |
GO:0006359 |
2.43% |
regulation of transcription by RNA polymerase III |
GO:0006282 |
2.43% |
regulation of DNA repair |
GO:0030100 |
2.43% |
regulation of endocytosis |
GO:2000737 |
2.42% |
negative regulation of stem cell differentiation |
GO:0048229 |
2.42% |
gametophyte development |
GO:0007160 |
2.42% |
cell-matrix adhesion |
GO:0016071 |
2.41% |
mRNA metabolic process |
GO:1905332 |
2.41% |
positive regulation of morphogenesis of an epithelium |
GO:0042113 |
2.41% |
B cell activation |
GO:0006790 |
2.41% |
sulfur compound metabolic process |
GO:0031331 |
2.41% |
positive regulation of cellular catabolic process |
GO:0030218 |
2.41% |
erythrocyte differentiation |
GO:0043534 |
2.41% |
blood vessel endothelial cell migration |
GO:1905393 |
2.41% |
plant organ formation |
GO:0070830 |
2.41% |
bicellular tight junction assembly |
GO:0032869 |
2.40% |
cellular response to insulin stimulus |
GO:1902806 |
2.40% |
regulation of cell cycle G1/S phase transition |
GO:0031345 |
2.40% |
negative regulation of cell projection organization |
GO:1901655 |
2.40% |
cellular response to ketone |
GO:0000083 |
2.40% |
regulation of transcription involved in G1/S transition of mitotic cell cycle |
GO:0010675 |
2.40% |
regulation of cellular carbohydrate metabolic process |
GO:0006464 |
2.40% |
cellular protein modification process |
GO:0032024 |
2.40% |
positive regulation of insulin secretion |
GO:0008542 |
2.40% |
visual learning |
GO:0045670 |
2.39% |
regulation of osteoclast differentiation |
GO:0036211 |
2.39% |
protein modification process |
GO:0001775 |
2.39% |
cell activation |
GO:0050804 |
2.39% |
modulation of chemical synaptic transmission |
GO:0034285 |
2.39% |
response to disaccharide |
GO:0045843 |
2.38% |
negative regulation of striated muscle tissue development |
GO:0050818 |
2.38% |
regulation of coagulation |
GO:0006259 |
2.38% |
DNA metabolic process |
GO:0060964 |
2.38% |
regulation of gene silencing by miRNA |
GO:1902115 |
2.37% |
regulation of organelle assembly |
GO:0042749 |
2.37% |
regulation of circadian sleep/wake cycle |
GO:0032816 |
2.37% |
positive regulation of natural killer cell activation |
GO:0043620 |
2.37% |
regulation of DNA-templated transcription in response to stress |
GO:0032271 |
2.37% |
regulation of protein polymerization |
GO:0017038 |
2.36% |
protein import |
GO:0060251 |
2.36% |
regulation of glial cell proliferation |
GO:0071331 |
2.36% |
cellular response to hexose stimulus |
GO:0071478 |
2.36% |
cellular response to radiation |
GO:0032984 |
2.36% |
protein-containing complex disassembly |
GO:0046885 |
2.36% |
regulation of hormone biosynthetic process |
GO:0043401 |
2.36% |
steroid hormone mediated signaling pathway |
GO:0003143 |
2.36% |
embryonic heart tube morphogenesis |
GO:0032092 |
2.36% |
positive regulation of protein binding |
GO:0071852 |
2.35% |
fungal-type cell wall organization or biogenesis |
GO:0002062 |
2.34% |
chondrocyte differentiation |
GO:0043618 |
2.34% |
regulation of transcription from RNA polymerase II promoter in response to stress |
GO:0050771 |
2.34% |
negative regulation of axonogenesis |
GO:1903046 |
2.34% |
meiotic cell cycle process |
GO:1901184 |
2.33% |
regulation of ERBB signaling pathway |
GO:0010977 |
2.33% |
negative regulation of neuron projection development |
GO:0097009 |
2.33% |
energy homeostasis |
GO:0051896 |
2.33% |
regulation of protein kinase B signaling |
GO:0002285 |
2.33% |
lymphocyte activation involved in immune response |
GO:0120192 |
2.33% |
tight junction assembly |
GO:0061178 |
2.33% |
regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:0034333 |
2.32% |
adherens junction assembly |
GO:2000758 |
2.32% |
positive regulation of peptidyl-lysine acetylation |
GO:0030447 |
2.32% |
filamentous growth |
GO:0016925 |
2.32% |
protein sumoylation |
GO:0001756 |
2.32% |
somitogenesis |
GO:0033081 |
2.32% |
regulation of T cell differentiation in thymus |
GO:0048636 |
2.32% |
positive regulation of muscle organ development |
GO:2001234 |
2.31% |
negative regulation of apoptotic signaling pathway |
GO:0006997 |
2.31% |
nucleus organization |
GO:0045785 |
2.31% |
positive regulation of cell adhesion |
GO:0048366 |
2.30% |
leaf development |
GO:0042698 |
2.30% |
ovulation cycle |
GO:0032388 |
2.30% |
positive regulation of intracellular transport |
GO:0030193 |
2.30% |
regulation of blood coagulation |
GO:2000377 |
2.30% |
regulation of reactive oxygen species metabolic process |
GO:1900376 |
2.29% |
regulation of secondary metabolite biosynthetic process |
GO:0031069 |
2.29% |
hair follicle morphogenesis |
GO:0021955 |
2.28% |
central nervous system neuron axonogenesis |
GO:0003281 |
2.28% |
ventricular septum development |
GO:0051293 |
2.28% |
establishment of spindle localization |
GO:0050810 |
2.28% |
regulation of steroid biosynthetic process |
GO:0051569 |
2.28% |
regulation of histone H3-K4 methylation |
GO:0042058 |
2.28% |
regulation of epidermal growth factor receptor signaling pathway |
GO:0035150 |
2.28% |
regulation of tube size |
GO:0051781 |
2.28% |
positive regulation of cell division |
GO:0055067 |
2.28% |
monovalent inorganic cation homeostasis |
GO:0008360 |
2.28% |
regulation of cell shape |
GO:0031061 |
2.28% |
negative regulation of histone methylation |
GO:0010828 |
2.27% |
positive regulation of glucose transmembrane transport |
GO:0046605 |
2.27% |
regulation of centrosome cycle |
GO:0009793 |
2.27% |
embryo development ending in seed dormancy |
GO:0045912 |
2.27% |
negative regulation of carbohydrate metabolic process |
GO:0042481 |
2.27% |
regulation of odontogenesis |
GO:0000723 |
2.26% |
telomere maintenance |
GO:0120193 |
2.26% |
tight junction organization |
GO:0009593 |
2.26% |
detection of chemical stimulus |
GO:0061982 |
2.26% |
meiosis I cell cycle process |
GO:0003279 |
2.26% |
cardiac septum development |
GO:2001252 |
2.26% |
positive regulation of chromosome organization |
GO:0031589 |
2.26% |
cell-substrate adhesion |
GO:0003018 |
2.26% |
vascular process in circulatory system |
GO:0043434 |
2.25% |
response to peptide hormone |
GO:1903036 |
2.25% |
positive regulation of response to wounding |
GO:0046887 |
2.24% |
positive regulation of hormone secretion |
GO:0050714 |
2.24% |
positive regulation of protein secretion |
GO:0044182 |
2.24% |
filamentous growth of a population of unicellular organisms |
GO:0006955 |
2.23% |
immune response |
GO:1902930 |
2.23% |
regulation of alcohol biosynthetic process |
GO:0055078 |
2.23% |
sodium ion homeostasis |
GO:0031400 |
2.22% |
negative regulation of protein modification process |
GO:1900151 |
2.22% |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO:0002366 |
2.21% |
leukocyte activation involved in immune response |
GO:0006356 |
2.21% |
regulation of transcription by RNA polymerase I |
GO:2000378 |
2.21% |
negative regulation of reactive oxygen species metabolic process |
GO:0051653 |
2.21% |
spindle localization |
GO:0051341 |
2.21% |
regulation of oxidoreductase activity |
GO:0006979 |
2.20% |
response to oxidative stress |
GO:0048827 |
2.20% |
phyllome development |
GO:0070417 |
2.20% |
cellular response to cold |
GO:0042335 |
2.20% |
cuticle development |
GO:0060674 |
2.20% |
placenta blood vessel development |
GO:0007015 |
2.19% |
actin filament organization |
GO:0007224 |
2.19% |
smoothened signaling pathway |
GO:0034332 |
2.19% |
adherens junction organization |
GO:0097237 |
2.19% |
cellular response to toxic substance |
GO:0010677 |
2.18% |
negative regulation of cellular carbohydrate metabolic process |
GO:0014072 |
2.18% |
response to isoquinoline alkaloid |
GO:0032956 |
2.18% |
regulation of actin cytoskeleton organization |
GO:0045661 |
2.18% |
regulation of myoblast differentiation |
GO:0000086 |
2.17% |
G2/M transition of mitotic cell cycle |
GO:0021915 |
2.17% |
neural tube development |
GO:0001936 |
2.17% |
regulation of endothelial cell proliferation |
GO:0042551 |
2.17% |
neuron maturation |
GO:0071214 |
2.17% |
cellular response to abiotic stimulus |
GO:0040001 |
2.17% |
establishment of mitotic spindle localization |
GO:0030261 |
2.16% |
chromosome condensation |
GO:0009744 |
2.16% |
response to sucrose |
GO:0043436 |
2.16% |
oxoacid metabolic process |
GO:0032273 |
2.16% |
positive regulation of protein polymerization |
GO:0120034 |
2.16% |
positive regulation of plasma membrane bounded cell projection assembly |
GO:0010906 |
2.15% |
regulation of glucose metabolic process |
GO:0045321 |
2.15% |
leukocyte activation |
GO:0042110 |
2.15% |
T cell activation |
GO:0046326 |
2.15% |
positive regulation of glucose import |
GO:0001817 |
2.15% |
regulation of cytokine production |
GO:0060976 |
2.15% |
coronary vasculature development |
GO:0032094 |
2.14% |
response to food |
GO:0008217 |
2.14% |
regulation of blood pressure |
GO:0043486 |
2.14% |
histone exchange |
GO:0071276 |
2.14% |
cellular response to cadmium ion |
GO:0046148 |
2.14% |
pigment biosynthetic process |
GO:0060281 |
2.13% |
regulation of oocyte development |
GO:0014068 |
2.13% |
positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0030833 |
2.13% |
regulation of actin filament polymerization |
GO:0002200 |
2.13% |
somatic diversification of immune receptors |
GO:0010959 |
2.12% |
regulation of metal ion transport |
GO:0007076 |
2.12% |
mitotic chromosome condensation |
GO:1901890 |
2.12% |
positive regulation of cell junction assembly |
GO:0043269 |
2.12% |
regulation of ion transport |
GO:0019216 |
2.12% |
regulation of lipid metabolic process |
GO:0090329 |
2.12% |
regulation of DNA-dependent DNA replication |
GO:0071559 |
2.12% |
response to transforming growth factor beta |
GO:0008064 |
2.12% |
regulation of actin polymerization or depolymerization |
GO:0006082 |
2.12% |
organic acid metabolic process |
GO:1901796 |
2.12% |
regulation of signal transduction by p53 class mediator |
GO:0044550 |
2.11% |
secondary metabolite biosynthetic process |
GO:0043044 |
2.11% |
ATP-dependent chromatin remodeling |
GO:0001539 |
2.11% |
cilium or flagellum-dependent cell motility |
GO:0045621 |
2.11% |
positive regulation of lymphocyte differentiation |
GO:0030518 |
2.10% |
intracellular steroid hormone receptor signaling pathway |
GO:0035690 |
2.10% |
cellular response to drug |
GO:0030838 |
2.10% |
positive regulation of actin filament polymerization |
GO:0071554 |
2.10% |
cell wall organization or biogenesis |
GO:0104004 |
2.10% |
cellular response to environmental stimulus |
GO:0072503 |
2.09% |
cellular divalent inorganic cation homeostasis |
GO:0002263 |
2.09% |
cell activation involved in immune response |
GO:0032922 |
2.09% |
circadian regulation of gene expression |
GO:0009734 |
2.09% |
auxin-activated signaling pathway |
GO:0009617 |
2.09% |
response to bacterium |
GO:0070726 |
2.09% |
cell wall assembly |
GO:0046916 |
2.09% |
cellular transition metal ion homeostasis |
GO:0031646 |
2.08% |
positive regulation of nervous system process |
GO:1902808 |
2.08% |
positive regulation of cell cycle G1/S phase transition |
GO:0098900 |
2.08% |
regulation of action potential |
GO:0042762 |
2.08% |
regulation of sulfur metabolic process |
GO:1902749 |
2.08% |
regulation of cell cycle G2/M phase transition |
GO:0060285 |
2.08% |
cilium-dependent cell motility |
GO:0016584 |
2.07% |
nucleosome positioning |
GO:0060099 |
2.07% |
regulation of phagocytosis, engulfment |
GO:0035020 |
2.07% |
regulation of Rac protein signal transduction |
GO:1903779 |
2.07% |
regulation of cardiac conduction |
GO:0045740 |
2.07% |
positive regulation of DNA replication |
GO:0009909 |
2.07% |
regulation of flower development |
GO:0071482 |
2.07% |
cellular response to light stimulus |
GO:0006367 |
2.07% |
transcription initiation from RNA polymerase II promoter |
GO:1901652 |
2.07% |
response to peptide |
GO:0001819 |
2.07% |
positive regulation of cytokine production |
GO:0098813 |
2.07% |
nuclear chromosome segregation |
GO:0035188 |
2.07% |
hatching |
GO:0090398 |
2.07% |
cellular senescence |
GO:0001942 |
2.06% |
hair follicle development |
GO:0009860 |
2.06% |
pollen tube growth |
GO:1905562 |
2.06% |
regulation of vascular endothelial cell proliferation |
GO:0007566 |
2.06% |
embryo implantation |
GO:1901566 |
2.06% |
organonitrogen compound biosynthetic process |
GO:0080135 |
2.06% |
regulation of cellular response to stress |
GO:0070783 |
2.06% |
growth of unicellular organism as a thread of attached cells |
GO:0051123 |
2.05% |
RNA polymerase II preinitiation complex assembly |
GO:0033561 |
2.05% |
regulation of water loss via skin |
GO:0010476 |
2.05% |
gibberellin mediated signaling pathway |
GO:0055010 |
2.05% |
ventricular cardiac muscle tissue morphogenesis |
GO:1903831 |
2.05% |
signal transduction involved in cellular response to ammonium ion |
GO:0031060 |
2.05% |
regulation of histone methylation |
GO:0032259 |
2.05% |
methylation |
GO:0060148 |
2.05% |
positive regulation of posttranscriptional gene silencing |
GO:0032200 |
2.04% |
telomere organization |
GO:0033143 |
2.04% |
regulation of intracellular steroid hormone receptor signaling pathway |
GO:0031330 |
2.04% |
negative regulation of cellular catabolic process |
GO:0002286 |
2.04% |
T cell activation involved in immune response |
GO:0009737 |
2.04% |
response to abscisic acid |
GO:0016202 |
2.04% |
regulation of striated muscle tissue development |
GO:0009584 |
2.03% |
detection of visible light |
GO:0048538 |
2.03% |
thymus development |
GO:2000279 |
2.03% |
negative regulation of DNA biosynthetic process |
GO:0048285 |
2.03% |
organelle fission |
GO:0098542 |
2.03% |
defense response to other organism |
GO:0048509 |
2.03% |
regulation of meristem development |
GO:0019915 |
2.03% |
lipid storage |
GO:1901160 |
2.02% |
primary amino compound metabolic process |
GO:0006310 |
2.02% |
DNA recombination |
GO:0097421 |
2.02% |
liver regeneration |
GO:1902253 |
2.02% |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0001678 |
2.02% |
cellular glucose homeostasis |
GO:2001025 |
2.01% |
positive regulation of response to drug |
GO:0055074 |
2.01% |
calcium ion homeostasis |
GO:0007616 |
2.01% |
long-term memory |
GO:0009409 |
2.01% |
response to cold |
GO:0007140 |
2.01% |
male meiotic nuclear division |
GO:0071236 |
2.01% |
cellular response to antibiotic |
GO:0061572 |
2.00% |
actin filament bundle organization |
GO:0071417 |
2.00% |
cellular response to organonitrogen compound |
GO:1902533 |
2.00% |
positive regulation of intracellular signal transduction |
GO:0032102 |
2.00% |
negative regulation of response to external stimulus |
GO:0009740 |
2.00% |
gibberellic acid mediated signaling pathway |
GO:0014066 |
1.99% |
regulation of phosphatidylinositol 3-kinase signaling |
GO:0002562 |
1.99% |
somatic diversification of immune receptors via germline recombination within a single locus |
GO:0030832 |
1.99% |
regulation of actin filament length |
GO:0006396 |
1.99% |
RNA processing |
GO:0007051 |
1.99% |
spindle organization |
GO:0030514 |
1.99% |
negative regulation of BMP signaling pathway |
GO:0035813 |
1.98% |
regulation of renal sodium excretion |
GO:0006606 |
1.98% |
protein import into nucleus |
GO:0055076 |
1.98% |
transition metal ion homeostasis |
GO:0060968 |
1.98% |
regulation of gene silencing |
GO:0010592 |
1.98% |
positive regulation of lamellipodium assembly |
GO:2001233 |
1.98% |
regulation of apoptotic signaling pathway |
GO:0033157 |
1.98% |
regulation of intracellular protein transport |
GO:1901985 |
1.98% |
positive regulation of protein acetylation |
GO:0050766 |
1.98% |
positive regulation of phagocytosis |
GO:0007212 |
1.97% |
dopamine receptor signaling pathway |
GO:2000104 |
1.97% |
negative regulation of DNA-dependent DNA replication |
GO:0032649 |
1.97% |
regulation of interferon-gamma production |
GO:1905269 |
1.97% |
positive regulation of chromatin organization |
GO:1901699 |
1.96% |
cellular response to nitrogen compound |
GO:0022413 |
1.96% |
reproductive process in single-celled organism |
GO:0048641 |
1.96% |
regulation of skeletal muscle tissue development |
GO:0070849 |
1.96% |
response to epidermal growth factor |
GO:0033120 |
1.96% |
positive regulation of RNA splicing |
GO:0046697 |
1.96% |
decidualization |
GO:0060420 |
1.96% |
regulation of heart growth |
GO:0010507 |
1.96% |
negative regulation of autophagy |
GO:0060259 |
1.96% |
regulation of feeding behavior |
GO:0051782 |
1.95% |
negative regulation of cell division |
GO:0001824 |
1.95% |
blastocyst development |
GO:0043567 |
1.95% |
regulation of insulin-like growth factor receptor signaling pathway |
GO:0009932 |
1.95% |
cell tip growth |
GO:0007569 |
1.95% |
cell aging |
GO:0034063 |
1.95% |
stress granule assembly |
GO:0098751 |
1.95% |
bone cell development |
GO:0010939 |
1.94% |
regulation of necrotic cell death |
GO:1901617 |
1.94% |
organic hydroxy compound biosynthetic process |
GO:0051051 |
1.94% |
negative regulation of transport |
GO:0030317 |
1.94% |
flagellated sperm motility |
GO:0000280 |
1.94% |
nuclear division |
GO:0048771 |
1.94% |
tissue remodeling |
GO:0045582 |
1.94% |
positive regulation of T cell differentiation |
GO:1901532 |
1.94% |
regulation of hematopoietic progenitor cell differentiation |
GO:0007613 |
1.94% |
memory |
GO:0000018 |
1.93% |
regulation of DNA recombination |
GO:0008610 |
1.93% |
lipid biosynthetic process |
GO:0006638 |
1.93% |
neutral lipid metabolic process |
GO:0045987 |
1.93% |
positive regulation of smooth muscle contraction |
GO:0006639 |
1.93% |
acylglycerol metabolic process |
GO:0010259 |
1.93% |
multicellular organism aging |
GO:0031100 |
1.93% |
animal organ regeneration |
GO:0051321 |
1.93% |
meiotic cell cycle |
GO:0045648 |
1.92% |
positive regulation of erythrocyte differentiation |
GO:1902531 |
1.92% |
regulation of intracellular signal transduction |
GO:0006323 |
1.92% |
DNA packaging |
GO:0043457 |
1.92% |
regulation of cellular respiration |
GO:0034765 |
1.92% |
regulation of ion transmembrane transport |
GO:0048364 |
1.92% |
root development |
GO:0030437 |
1.91% |
ascospore formation |
GO:0060326 |
1.91% |
cell chemotaxis |
GO:0051354 |
1.91% |
negative regulation of oxidoreductase activity |
GO:0044728 |
1.91% |
DNA methylation or demethylation |
GO:0051153 |
1.91% |
regulation of striated muscle cell differentiation |
GO:0035066 |
1.91% |
positive regulation of histone acetylation |
GO:0098657 |
1.90% |
import into cell |
GO:0007638 |
1.90% |
mechanosensory behavior |
GO:0010528 |
1.90% |
regulation of transposition |
GO:0031063 |
1.90% |
regulation of histone deacetylation |
GO:1902991 |
1.90% |
regulation of amyloid precursor protein catabolic process |
GO:0045933 |
1.90% |
positive regulation of muscle contraction |
GO:0016445 |
1.90% |
somatic diversification of immunoglobulins |
GO:2000757 |
1.90% |
negative regulation of peptidyl-lysine acetylation |
GO:0019439 |
1.90% |
aromatic compound catabolic process |
GO:0090303 |
1.90% |
positive regulation of wound healing |
GO:0010029 |
1.89% |
regulation of seed germination |
GO:0001818 |
1.89% |
negative regulation of cytokine production |
GO:0051259 |
1.89% |
protein complex oligomerization |
GO:0051931 |
1.89% |
regulation of sensory perception |
GO:1901984 |
1.89% |
negative regulation of protein acetylation |
GO:0042303 |
1.89% |
molting cycle |
GO:0006468 |
1.89% |
protein phosphorylation |
GO:0002521 |
1.89% |
leukocyte differentiation |
GO:2001242 |
1.89% |
regulation of intrinsic apoptotic signaling pathway |
GO:0030431 |
1.89% |
sleep |
GO:0046631 |
1.88% |
alpha-beta T cell activation |
GO:0030435 |
1.88% |
sporulation resulting in formation of a cellular spore |
GO:1902003 |
1.88% |
regulation of amyloid-beta formation |
GO:0071375 |
1.88% |
cellular response to peptide hormone stimulus |
GO:1902745 |
1.88% |
positive regulation of lamellipodium organization |
GO:0044764 |
1.88% |
multi-organism cellular process |
GO:0019932 |
1.88% |
second-messenger-mediated signaling |
GO:0055088 |
1.88% |
lipid homeostasis |
GO:0006995 |
1.88% |
cellular response to nitrogen starvation |
GO:0044270 |
1.88% |
cellular nitrogen compound catabolic process |
GO:2000637 |
1.87% |
positive regulation of gene silencing by miRNA |
GO:0007043 |
1.87% |
cell-cell junction assembly |
GO:0006304 |
1.87% |
DNA modification |
GO:0090175 |
1.87% |
regulation of establishment of planar polarity |
GO:2000045 |
1.87% |
regulation of G1/S transition of mitotic cell cycle |
GO:0045472 |
1.87% |
response to ether |
GO:0002335 |
1.86% |
mature B cell differentiation |
GO:0032986 |
1.86% |
protein-DNA complex disassembly |
GO:0016310 |
1.86% |
phosphorylation |
GO:0031334 |
1.85% |
positive regulation of protein complex assembly |
GO:0035774 |
1.85% |
positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:0009624 |
1.85% |
response to nematode |
GO:0044070 |
1.85% |
regulation of anion transport |
GO:0001541 |
1.85% |
ovarian follicle development |
GO:0051640 |
1.85% |
organelle localization |
GO:0099120 |
1.85% |
socially cooperative development |
GO:0002237 |
1.85% |
response to molecule of bacterial origin |
GO:0043414 |
1.85% |
macromolecule methylation |
GO:0008643 |
1.85% |
carbohydrate transport |
GO:1900140 |
1.84% |
regulation of seedling development |
GO:0050777 |
1.84% |
negative regulation of immune response |
GO:0055070 |
1.84% |
copper ion homeostasis |
GO:1904659 |
1.84% |
glucose transmembrane transport |
GO:0050790 |
1.84% |
regulation of catalytic activity |
GO:0046632 |
1.84% |
alpha-beta T cell differentiation |
GO:0048167 |
1.84% |
regulation of synaptic plasticity |
GO:0002252 |
1.84% |
immune effector process |
GO:0044085 |
1.84% |
cellular component biogenesis |
GO:0043949 |
1.83% |
regulation of cAMP-mediated signaling |
GO:0031641 |
1.83% |
regulation of myelination |
GO:0034110 |
1.83% |
regulation of homotypic cell-cell adhesion |
GO:0006334 |
1.83% |
nucleosome assembly |
GO:0032675 |
1.83% |
regulation of interleukin-6 production |
GO:0043542 |
1.83% |
endothelial cell migration |
GO:0031137 |
1.83% |
regulation of conjugation with cellular fusion |
GO:0097722 |
1.83% |
sperm motility |
GO:0060491 |
1.82% |
regulation of cell projection assembly |
GO:0140013 |
1.82% |
meiotic nuclear division |
GO:0006306 |
1.82% |
DNA methylation |
GO:0043935 |
1.82% |
sexual sporulation resulting in formation of a cellular spore |
GO:0048873 |
1.82% |
homeostasis of number of cells within a tissue |
GO:0010837 |
1.81% |
regulation of keratinocyte proliferation |
GO:0022407 |
1.81% |
regulation of cell-cell adhesion |
GO:0061036 |
1.81% |
positive regulation of cartilage development |
GO:0033688 |
1.81% |
regulation of osteoblast proliferation |
GO:1903312 |
1.81% |
negative regulation of mRNA metabolic process |
GO:0045088 |
1.81% |
regulation of innate immune response |
GO:0009299 |
1.80% |
mRNA transcription |
GO:0000132 |
1.80% |
establishment of mitotic spindle orientation |
GO:0031532 |
1.80% |
actin cytoskeleton reorganization |
GO:0009582 |
1.80% |
detection of abiotic stimulus |
GO:0051965 |
1.80% |
positive regulation of synapse assembly |
GO:0090311 |
1.80% |
regulation of protein deacetylation |
GO:0032814 |
1.80% |
regulation of natural killer cell activation |
GO:0035637 |
1.80% |
multicellular organismal signaling |
GO:0044706 |
1.80% |
multi-multicellular organism process |
GO:0061013 |
1.79% |
regulation of mRNA catabolic process |
GO:0014031 |
1.79% |
mesenchymal cell development |
GO:0051235 |
1.79% |
maintenance of location |
GO:0016444 |
1.79% |
somatic cell DNA recombination |
GO:0006641 |
1.79% |
triglyceride metabolic process |
GO:0010883 |
1.79% |
regulation of lipid storage |
GO:1903429 |
1.79% |
regulation of cell maturation |
GO:0006878 |
1.79% |
cellular copper ion homeostasis |
GO:0120032 |
1.78% |
regulation of plasma membrane bounded cell projection assembly |
GO:0032204 |
1.78% |
regulation of telomere maintenance |
GO:0016567 |
1.78% |
protein ubiquitination |
GO:0009581 |
1.78% |
detection of external stimulus |
GO:0030239 |
1.78% |
myofibril assembly |
GO:0010508 |
1.78% |
positive regulation of autophagy |
GO:0051055 |
1.78% |
negative regulation of lipid biosynthetic process |
GO:0045216 |
1.78% |
cell-cell junction organization |
GO:0031139 |
1.77% |
positive regulation of conjugation with cellular fusion |
GO:1904062 |
1.77% |
regulation of cation transmembrane transport |
GO:0006909 |
1.77% |
phagocytosis |
GO:0032729 |
1.77% |
positive regulation of interferon-gamma production |
GO:0098586 |
1.77% |
cellular response to virus |
GO:0051154 |
1.77% |
negative regulation of striated muscle cell differentiation |
GO:0043934 |
1.77% |
sporulation |
GO:0060706 |
1.77% |
cell differentiation involved in embryonic placenta development |
GO:0018958 |
1.76% |
phenol-containing compound metabolic process |
GO:0072529 |
1.76% |
pyrimidine-containing compound catabolic process |
GO:0048524 |
1.76% |
positive regulation of viral process |
GO:0046700 |
1.76% |
heterocycle catabolic process |
GO:0051606 |
1.76% |
detection of stimulus |
GO:0043278 |
1.76% |
response to morphine |
GO:0009895 |
1.76% |
negative regulation of catabolic process |
GO:0046999 |
1.75% |
regulation of conjugation |
GO:0062014 |
1.75% |
negative regulation of small molecule metabolic process |
GO:0033014 |
1.75% |
tetrapyrrole biosynthetic process |
GO:0045911 |
1.75% |
positive regulation of DNA recombination |
GO:0008361 |
1.75% |
regulation of cell size |
GO:0018193 |
1.75% |
peptidyl-amino acid modification |
GO:2001243 |
1.75% |
negative regulation of intrinsic apoptotic signaling pathway |
GO:0090257 |
1.75% |
regulation of muscle system process |
GO:0046890 |
1.75% |
regulation of lipid biosynthetic process |
GO:0045229 |
1.75% |
external encapsulating structure organization |
GO:0043966 |
1.75% |
histone H3 acetylation |
GO:0033189 |
1.75% |
response to vitamin A |
GO:0006694 |
1.74% |
steroid biosynthetic process |
GO:0045739 |
1.74% |
positive regulation of DNA repair |
GO:0055081 |
1.74% |
anion homeostasis |
GO:0080154 |
1.74% |
regulation of fertilization |
GO:0070670 |
1.74% |
response to interleukin-4 |
GO:1903313 |
1.73% |
positive regulation of mRNA metabolic process |
GO:0008630 |
1.73% |
intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0045601 |
1.73% |
regulation of endothelial cell differentiation |
GO:0031136 |
1.73% |
positive regulation of conjugation |
GO:0072527 |
1.72% |
pyrimidine-containing compound metabolic process |
GO:1905153 |
1.72% |
regulation of membrane invagination |
GO:0018195 |
1.72% |
peptidyl-arginine modification |
GO:0098901 |
1.72% |
regulation of cardiac muscle cell action potential |
GO:0051188 |
1.72% |
cofactor biosynthetic process |
GO:0016053 |
1.72% |
organic acid biosynthetic process |
GO:0009404 |
1.72% |
toxin metabolic process |
GO:1902905 |
1.72% |
positive regulation of supramolecular fiber organization |
GO:1903053 |
1.72% |
regulation of extracellular matrix organization |
GO:1902170 |
1.72% |
cellular response to reactive nitrogen species |
GO:0006879 |
1.72% |
cellular iron ion homeostasis |
GO:0007044 |
1.71% |
cell-substrate junction assembly |
GO:0032570 |
1.71% |
response to progesterone |
GO:0098801 |
1.71% |
regulation of renal system process |
GO:0008645 |
1.71% |
hexose transmembrane transport |
GO:1902993 |
1.71% |
positive regulation of amyloid precursor protein catabolic process |
GO:0015749 |
1.71% |
monosaccharide transmembrane transport |
GO:2000024 |
1.71% |
regulation of leaf development |
GO:0044772 |
1.71% |
mitotic cell cycle phase transition |
GO:1900087 |
1.71% |
positive regulation of G1/S transition of mitotic cell cycle |
GO:0045132 |
1.71% |
meiotic chromosome segregation |
GO:0045943 |
1.70% |
positive regulation of transcription by RNA polymerase I |
GO:0007097 |
1.70% |
nuclear migration |
GO:0010575 |
1.70% |
positive regulation of vascular endothelial growth factor production |
GO:0002698 |
1.70% |
negative regulation of immune effector process |
GO:0032206 |
1.70% |
positive regulation of telomere maintenance |
GO:1904892 |
1.70% |
regulation of receptor signaling pathway via STAT |
GO:0051930 |
1.70% |
regulation of sensory perception of pain |
GO:0001776 |
1.70% |
leukocyte homeostasis |
GO:0033013 |
1.70% |
tetrapyrrole metabolic process |
GO:0031102 |
1.69% |
neuron projection regeneration |
GO:0044283 |
1.69% |
small molecule biosynthetic process |
GO:0043562 |
1.69% |
cellular response to nitrogen levels |
GO:0071555 |
1.69% |
cell wall organization |
GO:0006631 |
1.69% |
fatty acid metabolic process |
GO:0001944 |
1.69% |
vasculature development |
GO:0048821 |
1.69% |
erythrocyte development |
GO:0046683 |
1.68% |
response to organophosphorus |
GO:2000826 |
1.68% |
regulation of heart morphogenesis |
GO:0032755 |
1.68% |
positive regulation of interleukin-6 production |
GO:0007162 |
1.68% |
negative regulation of cell adhesion |
GO:0006473 |
1.68% |
protein acetylation |
GO:0043903 |
1.68% |
regulation of symbiosis, encompassing mutualism through parasitism |
GO:0051148 |
1.68% |
negative regulation of muscle cell differentiation |
GO:0031505 |
1.68% |
fungal-type cell wall organization |
GO:0002209 |
1.67% |
behavioral defense response |
GO:0030587 |
1.67% |
sorocarp development |
GO:0019752 |
1.67% |
carboxylic acid metabolic process |
GO:0046394 |
1.67% |
carboxylic acid biosynthetic process |
GO:0050921 |
1.67% |
positive regulation of chemotaxis |
GO:0033077 |
1.67% |
T cell differentiation in thymus |
GO:2000036 |
1.66% |
regulation of stem cell population maintenance |
GO:1905508 |
1.66% |
protein localization to microtubule organizing center |
GO:0032787 |
1.66% |
monocarboxylic acid metabolic process |
GO:0050994 |
1.66% |
regulation of lipid catabolic process |
GO:0014741 |
1.66% |
negative regulation of muscle hypertrophy |
GO:1901135 |
1.66% |
carbohydrate derivative metabolic process |
GO:0031058 |
1.66% |
positive regulation of histone modification |
GO:0042789 |
1.66% |
mRNA transcription by RNA polymerase II |
GO:0070542 |
1.66% |
response to fatty acid |
GO:0043086 |
1.66% |
negative regulation of catalytic activity |
GO:0050792 |
1.65% |
regulation of viral process |
GO:0061014 |
1.65% |
positive regulation of mRNA catabolic process |
GO:0098534 |
1.65% |
centriole assembly |
GO:0061337 |
1.65% |
cardiac conduction |
GO:1900026 |
1.65% |
positive regulation of substrate adhesion-dependent cell spreading |
GO:0070997 |
1.65% |
neuron death |
GO:1901797 |
1.65% |
negative regulation of signal transduction by p53 class mediator |
GO:0000003 |
1.65% |
reproduction |
GO:1901419 |
1.64% |
regulation of response to alcohol |
GO:0050918 |
1.64% |
positive chemotaxis |
GO:0034219 |
1.64% |
carbohydrate transmembrane transport |
GO:0071470 |
1.64% |
cellular response to osmotic stress |
GO:0010087 |
1.64% |
phloem or xylem histogenesis |
GO:0034766 |
1.64% |
negative regulation of ion transmembrane transport |
GO:0019221 |
1.64% |
cytokine-mediated signaling pathway |
GO:0044770 |
1.64% |
cell cycle phase transition |
GO:0009583 |
1.64% |
detection of light stimulus |
GO:0045910 |
1.64% |
negative regulation of DNA recombination |
GO:0016036 |
1.64% |
cellular response to phosphate starvation |
GO:0010669 |
1.64% |
epithelial structure maintenance |
GO:0045930 |
1.63% |
negative regulation of mitotic cell cycle |
GO:0043467 |
1.63% |
regulation of generation of precursor metabolites and energy |
GO:0009415 |
1.63% |
response to water |
GO:0002312 |
1.63% |
B cell activation involved in immune response |
GO:0090702 |
1.63% |
non-reproductive fruiting body development |
GO:0009414 |
1.63% |
response to water deprivation |
GO:0007127 |
1.63% |
meiosis I |
GO:0051647 |
1.63% |
nucleus localization |
GO:0034502 |
1.63% |
protein localization to chromosome |
GO:0071398 |
1.62% |
cellular response to fatty acid |
GO:0009268 |
1.62% |
response to pH |
GO:0032651 |
1.62% |
regulation of interleukin-1 beta production |
GO:0030199 |
1.62% |
collagen fibril organization |
GO:0010574 |
1.62% |
regulation of vascular endothelial growth factor production |
GO:0048545 |
1.62% |
response to steroid hormone |
GO:0045663 |
1.62% |
positive regulation of myoblast differentiation |
GO:0034763 |
1.62% |
negative regulation of transmembrane transport |
GO:0046189 |
1.62% |
phenol-containing compound biosynthetic process |
GO:0051260 |
1.62% |
protein homooligomerization |
GO:0043951 |
1.62% |
negative regulation of cAMP-mediated signaling |
GO:0070816 |
1.62% |
phosphorylation of RNA polymerase II C-terminal domain |
GO:0032467 |
1.61% |
positive regulation of cytokinesis |
GO:0071869 |
1.61% |
response to catecholamine |
GO:0006940 |
1.61% |
regulation of smooth muscle contraction |
GO:0043200 |
1.61% |
response to amino acid |
GO:0043455 |
1.61% |
regulation of secondary metabolic process |
GO:0034293 |
1.60% |
sexual sporulation |
GO:0010389 |
1.60% |
regulation of G2/M transition of mitotic cell cycle |
GO:0044419 |
1.60% |
interspecies interaction between organisms |
GO:0046579 |
1.60% |
positive regulation of Ras protein signal transduction |
GO:0016573 |
1.60% |
histone acetylation |
GO:0032496 |
1.59% |
response to lipopolysaccharide |
GO:0008156 |
1.59% |
negative regulation of DNA replication |
GO:0045862 |
1.59% |
positive regulation of proteolysis |
GO:0009408 |
1.59% |
response to heat |
GO:1902743 |
1.59% |
regulation of lamellipodium organization |
GO:0006783 |
1.59% |
heme biosynthetic process |
GO:0044843 |
1.59% |
cell cycle G1/S phase transition |
GO:1905957 |
1.59% |
regulation of cellular response to alcohol |
GO:0006446 |
1.59% |
regulation of translational initiation |
GO:0006959 |
1.59% |
humoral immune response |
GO:0014032 |
1.58% |
neural crest cell development |
GO:1901615 |
1.58% |
organic hydroxy compound metabolic process |
GO:0002028 |
1.58% |
regulation of sodium ion transport |
GO:0006508 |
1.58% |
proteolysis |
GO:0008299 |
1.58% |
isoprenoid biosynthetic process |
GO:0050684 |
1.57% |
regulation of mRNA processing |
GO:0045087 |
1.57% |
innate immune response |
GO:0006778 |
1.57% |
porphyrin-containing compound metabolic process |
GO:0051592 |
1.57% |
response to calcium ion |
GO:0045992 |
1.57% |
negative regulation of embryonic development |
GO:0051402 |
1.57% |
neuron apoptotic process |
GO:0018394 |
1.57% |
peptidyl-lysine acetylation |
GO:0016571 |
1.57% |
histone methylation |
GO:0008206 |
1.57% |
bile acid metabolic process |
GO:1903421 |
1.57% |
regulation of synaptic vesicle recycling |
GO:0006305 |
1.57% |
DNA alkylation |
GO:1904035 |
1.57% |
regulation of epithelial cell apoptotic process |
GO:0022408 |
1.56% |
negative regulation of cell-cell adhesion |
GO:2000278 |
1.56% |
regulation of DNA biosynthetic process |
GO:1903010 |
1.56% |
regulation of bone development |
GO:0007595 |
1.56% |
lactation |
GO:1901653 |
1.56% |
cellular response to peptide |
GO:0048741 |
1.56% |
skeletal muscle fiber development |
GO:0090698 |
1.55% |
post-embryonic plant morphogenesis |
GO:0010332 |
1.55% |
response to gamma radiation |
GO:0044839 |
1.55% |
cell cycle G2/M phase transition |
GO:0001961 |
1.55% |
positive regulation of cytokine-mediated signaling pathway |
GO:0045807 |
1.55% |
positive regulation of endocytosis |
GO:0019933 |
1.55% |
cAMP-mediated signaling |
GO:0046486 |
1.55% |
glycerolipid metabolic process |
GO:0006779 |
1.55% |
porphyrin-containing compound biosynthetic process |
GO:0051604 |
1.55% |
protein maturation |
GO:0010591 |
1.55% |
regulation of lamellipodium assembly |
GO:0051294 |
1.55% |
establishment of spindle orientation |
GO:0048581 |
1.55% |
negative regulation of post-embryonic development |
GO:0007141 |
1.54% |
male meiosis I |
GO:0009630 |
1.54% |
gravitropism |
GO:0051495 |
1.54% |
positive regulation of cytoskeleton organization |
GO:0071168 |
1.54% |
protein localization to chromatin |
GO:0048747 |
1.54% |
muscle fiber development |
GO:0071229 |
1.54% |
cellular response to acid chemical |
GO:0035924 |
1.54% |
cellular response to vascular endothelial growth factor stimulus |
GO:0032890 |
1.54% |
regulation of organic acid transport |
GO:0016447 |
1.53% |
somatic recombination of immunoglobulin gene segments |
GO:0051591 |
1.53% |
response to cAMP |
GO:0006475 |
1.53% |
internal protein amino acid acetylation |
GO:0009845 |
1.53% |
seed germination |
GO:1900024 |
1.53% |
regulation of substrate adhesion-dependent cell spreading |
GO:0035902 |
1.53% |
response to immobilization stress |
GO:0007589 |
1.53% |
body fluid secretion |
GO:0043543 |
1.52% |
protein acylation |
GO:0045833 |
1.52% |
negative regulation of lipid metabolic process |
GO:0060412 |
1.52% |
ventricular septum morphogenesis |
GO:0045494 |
1.52% |
photoreceptor cell maintenance |
GO:0090316 |
1.52% |
positive regulation of intracellular protein transport |
GO:0061117 |
1.52% |
negative regulation of heart growth |
GO:0033144 |
1.52% |
negative regulation of intracellular steroid hormone receptor signaling pathway |
GO:2000273 |
1.52% |
positive regulation of signaling receptor activity |
GO:0006479 |
1.52% |
protein methylation |
GO:0014074 |
1.51% |
response to purine-containing compound |
GO:0009615 |
1.51% |
response to virus |
GO:0050686 |
1.51% |
negative regulation of mRNA processing |
GO:0032642 |
1.51% |
regulation of chemokine production |
GO:0051338 |
1.51% |
regulation of transferase activity |
GO:0051262 |
1.51% |
protein tetramerization |
GO:0070167 |
1.51% |
regulation of biomineral tissue development |
GO:0046425 |
1.51% |
regulation of receptor signaling pathway via JAK-STAT |
GO:0090567 |
1.51% |
reproductive shoot system development |
GO:0048367 |
1.51% |
shoot system development |
GO:0060760 |
1.51% |
positive regulation of response to cytokine stimulus |
GO:0016032 |
1.51% |
viral process |
GO:0022409 |
1.51% |
positive regulation of cell-cell adhesion |
GO:0097327 |
1.51% |
response to antineoplastic agent |
GO:0010830 |
1.51% |
regulation of myotube differentiation |
GO:1903317 |
1.51% |
regulation of protein maturation |
GO:0016241 |
1.50% |
regulation of macroautophagy |
GO:0042435 |
1.50% |
indole-containing compound biosynthetic process |
GO:0031440 |
1.50% |
regulation of mRNA 3'-end processing |
GO:0010811 |
1.50% |
positive regulation of cell-substrate adhesion |
GO:0007608 |
1.50% |
sensory perception of smell |
GO:0018393 |
1.50% |
internal peptidyl-lysine acetylation |
GO:0097066 |
1.50% |
response to thyroid hormone |
GO:0008213 |
1.50% |
protein alkylation |
GO:0070098 |
1.50% |
chemokine-mediated signaling pathway |
GO:1905392 |
1.49% |
plant organ morphogenesis |
GO:0045619 |
1.49% |
regulation of lymphocyte differentiation |
GO:1900180 |
1.49% |
regulation of protein localization to nucleus |
GO:0071560 |
1.49% |
cellular response to transforming growth factor beta stimulus |
GO:0050680 |
1.49% |
negative regulation of epithelial cell proliferation |
GO:0010660 |
1.49% |
regulation of muscle cell apoptotic process |
GO:0009867 |
1.49% |
jasmonic acid mediated signaling pathway |
GO:0016114 |
1.49% |
terpenoid biosynthetic process |
GO:0002292 |
1.49% |
T cell differentiation involved in immune response |
GO:0055072 |
1.48% |
iron ion homeostasis |
GO:0110053 |
1.48% |
regulation of actin filament organization |
GO:0006720 |
1.48% |
isoprenoid metabolic process |
GO:0009606 |
1.48% |
tropism |
GO:0010821 |
1.48% |
regulation of mitochondrion organization |
GO:0055026 |
1.48% |
negative regulation of cardiac muscle tissue development |
GO:1903319 |
1.48% |
positive regulation of protein maturation |
GO:0003179 |
1.47% |
heart valve morphogenesis |
GO:0002762 |
1.47% |
negative regulation of myeloid leukocyte differentiation |
GO:0030002 |
1.47% |
cellular anion homeostasis |
GO:1903829 |
1.47% |
positive regulation of cellular protein localization |
GO:0051057 |
1.47% |
positive regulation of small GTPase mediated signal transduction |
GO:1904036 |
1.47% |
negative regulation of epithelial cell apoptotic process |
GO:0006368 |
1.47% |
transcription elongation from RNA polymerase II promoter |
GO:1902117 |
1.47% |
positive regulation of organelle assembly |
GO:0045744 |
1.47% |
negative regulation of G protein-coupled receptor signaling pathway |
GO:0035418 |
1.47% |
protein localization to synapse |
GO:0021510 |
1.47% |
spinal cord development |
GO:0006897 |
1.47% |
endocytosis |
GO:0097696 |
1.47% |
receptor signaling pathway via STAT |
GO:2000765 |
1.47% |
regulation of cytoplasmic translation |
GO:0010662 |
1.47% |
regulation of striated muscle cell apoptotic process |
GO:0050867 |
1.46% |
positive regulation of cell activation |
GO:0007096 |
1.46% |
regulation of exit from mitosis |
GO:0032409 |
1.46% |
regulation of transporter activity |
GO:0071459 |
1.46% |
protein localization to chromosome, centromeric region |
GO:0000387 |
1.46% |
spliceosomal snRNP assembly |
GO:0061515 |
1.46% |
myeloid cell development |
GO:0030162 |
1.46% |
regulation of proteolysis |
GO:0001835 |
1.46% |
blastocyst hatching |
GO:2001038 |
1.46% |
regulation of cellular response to drug |
GO:0071867 |
1.46% |
response to monoamine |
GO:0042742 |
1.46% |
defense response to bacterium |
GO:0006882 |
1.46% |
cellular zinc ion homeostasis |
GO:0032368 |
1.45% |
regulation of lipid transport |
GO:0000381 |
1.45% |
regulation of alternative mRNA splicing, via spliceosome |
GO:0034754 |
1.45% |
cellular hormone metabolic process |
GO:0042770 |
1.45% |
signal transduction in response to DNA damage |
GO:0006354 |
1.45% |
DNA-templated transcription, elongation |
GO:0014003 |
1.45% |
oligodendrocyte development |
GO:0007259 |
1.45% |
receptor signaling pathway via JAK-STAT |
GO:1901863 |
1.45% |
positive regulation of muscle tissue development |
GO:0042168 |
1.45% |
heme metabolic process |
GO:0055022 |
1.45% |
negative regulation of cardiac muscle tissue growth |
GO:0048259 |
1.45% |
regulation of receptor-mediated endocytosis |
GO:0045948 |
1.45% |
positive regulation of translational initiation |
GO:0006721 |
1.45% |
terpenoid metabolic process |
GO:0035330 |
1.45% |
regulation of hippo signaling |
GO:0006584 |
1.44% |
catecholamine metabolic process |
GO:0000212 |
1.44% |
meiotic spindle organization |
GO:0006858 |
1.44% |
extracellular transport |
GO:1901998 |
1.44% |
toxin transport |
GO:0002040 |
1.44% |
sprouting angiogenesis |
GO:0032465 |
1.44% |
regulation of cytokinesis |
GO:0033146 |
1.44% |
regulation of intracellular estrogen receptor signaling pathway |
GO:0090207 |
1.43% |
regulation of triglyceride metabolic process |
GO:0006874 |
1.43% |
cellular calcium ion homeostasis |
GO:0031348 |
1.43% |
negative regulation of defense response |
GO:0071941 |
1.42% |
nitrogen cycle metabolic process |
GO:0009642 |
1.42% |
response to light intensity |
GO:0032480 |
1.42% |
negative regulation of type I interferon production |
GO:0010393 |
1.42% |
galacturonan metabolic process |
GO:0032954 |
1.42% |
regulation of cytokinetic process |
GO:0051225 |
1.42% |
spindle assembly |
GO:1903320 |
1.41% |
regulation of protein modification by small protein conjugation or removal |
GO:0071277 |
1.41% |
cellular response to calcium ion |
GO:0010665 |
1.41% |
regulation of cardiac muscle cell apoptotic process |
GO:0019935 |
1.41% |
cyclic-nucleotide-mediated signaling |
GO:0061436 |
1.41% |
establishment of skin barrier |
GO:0045921 |
1.41% |
positive regulation of exocytosis |
GO:0010565 |
1.41% |
regulation of cellular ketone metabolic process |
GO:0006406 |
1.41% |
mRNA export from nucleus |
GO:0034103 |
1.41% |
regulation of tissue remodeling |
GO:0009712 |
1.40% |
catechol-containing compound metabolic process |
GO:0051928 |
1.40% |
positive regulation of calcium ion transport |
GO:0042133 |
1.40% |
neurotransmitter metabolic process |
GO:0000082 |
1.40% |
G1/S transition of mitotic cell cycle |
GO:0032652 |
1.40% |
regulation of interleukin-1 production |
GO:1902373 |
1.39% |
negative regulation of mRNA catabolic process |
GO:0018023 |
1.39% |
peptidyl-lysine trimethylation |
GO:0048024 |
1.39% |
regulation of mRNA splicing, via spliceosome |
GO:1902369 |
1.38% |
negative regulation of RNA catabolic process |
GO:0016458 |
1.38% |
gene silencing |
GO:0031103 |
1.38% |
axon regeneration |
GO:0050805 |
1.38% |
negative regulation of synaptic transmission |
GO:0045776 |
1.38% |
negative regulation of blood pressure |
GO:0043570 |
1.38% |
maintenance of DNA repeat elements |
GO:0045580 |
1.38% |
regulation of T cell differentiation |
GO:0034655 |
1.38% |
nucleobase-containing compound catabolic process |
GO:0050829 |
1.38% |
defense response to Gram-negative bacterium |
GO:0051571 |
1.38% |
positive regulation of histone H3-K4 methylation |
GO:0007005 |
1.38% |
mitochondrion organization |
GO:0010614 |
1.37% |
negative regulation of cardiac muscle hypertrophy |
GO:0033273 |
1.37% |
response to vitamin |
GO:1903998 |
1.37% |
regulation of eating behavior |
GO:0034644 |
1.37% |
cellular response to UV |
GO:1901988 |
1.37% |
negative regulation of cell cycle phase transition |
GO:0045010 |
1.37% |
actin nucleation |
GO:0032680 |
1.37% |
regulation of tumor necrosis factor production |
GO:0016485 |
1.37% |
protein processing |
GO:0006939 |
1.37% |
smooth muscle contraction |
GO:0048017 |
1.37% |
inositol lipid-mediated signaling |
GO:0042546 |
1.37% |
cell wall biogenesis |
GO:0001974 |
1.37% |
blood vessel remodeling |
GO:0043367 |
1.36% |
CD4-positive, alpha-beta T cell differentiation |
GO:0030330 |
1.36% |
DNA damage response, signal transduction by p53 class mediator |
GO:0016973 |
1.36% |
poly(A)+ mRNA export from nucleus |
GO:0051261 |
1.36% |
protein depolymerization |
GO:0044247 |
1.36% |
cellular polysaccharide catabolic process |
GO:0048284 |
1.36% |
organelle fusion |
GO:0000302 |
1.36% |
response to reactive oxygen species |
GO:0032967 |
1.36% |
positive regulation of collagen biosynthetic process |
GO:1901361 |
1.36% |
organic cyclic compound catabolic process |
GO:0002696 |
1.36% |
positive regulation of leukocyte activation |
GO:0051251 |
1.36% |
positive regulation of lymphocyte activation |
GO:0014904 |
1.36% |
myotube cell development |
GO:0060135 |
1.36% |
maternal process involved in female pregnancy |
GO:0050727 |
1.36% |
regulation of inflammatory response |
GO:0022618 |
1.36% |
ribonucleoprotein complex assembly |
GO:0010831 |
1.35% |
positive regulation of myotube differentiation |
GO:0032924 |
1.35% |
activin receptor signaling pathway |
GO:0043484 |
1.35% |
regulation of RNA splicing |
GO:1904994 |
1.35% |
regulation of leukocyte adhesion to vascular endothelial cell |
GO:0016482 |
1.35% |
cytosolic transport |
GO:0035821 |
1.35% |
modification of morphology or physiology of other organism |
GO:0000725 |
1.35% |
recombinational repair |
GO:0009908 |
1.35% |
flower development |
GO:0071353 |
1.35% |
cellular response to interleukin-4 |
GO:0051491 |
1.34% |
positive regulation of filopodium assembly |
GO:2001244 |
1.34% |
positive regulation of intrinsic apoptotic signaling pathway |
GO:0002825 |
1.34% |
regulation of T-helper 1 type immune response |
GO:2001022 |
1.34% |
positive regulation of response to DNA damage stimulus |
GO:0006405 |
1.34% |
RNA export from nucleus |
GO:0003206 |
1.34% |
cardiac chamber morphogenesis |
GO:0033206 |
1.34% |
meiotic cytokinesis |
GO:0006954 |
1.33% |
inflammatory response |
GO:0044403 |
1.33% |
symbiotic process |
GO:0010765 |
1.33% |
positive regulation of sodium ion transport |
GO:0006397 |
1.32% |
mRNA processing |
GO:0032655 |
1.32% |
regulation of interleukin-12 production |
GO:0048678 |
1.32% |
response to axon injury |
GO:0031023 |
1.32% |
microtubule organizing center organization |
GO:0043500 |
1.32% |
muscle adaptation |
GO:0034389 |
1.32% |
lipid droplet organization |
GO:0010286 |
1.32% |
heat acclimation |
GO:0006888 |
1.32% |
endoplasmic reticulum to Golgi vesicle-mediated transport |
GO:0016570 |
1.31% |
histone modification |
GO:0045488 |
1.31% |
pectin metabolic process |
GO:0045793 |
1.31% |
positive regulation of cell size |
GO:0022600 |
1.31% |
digestive system process |
GO:0046824 |
1.31% |
positive regulation of nucleocytoplasmic transport |
GO:0009738 |
1.31% |
abscisic acid-activated signaling pathway |
GO:0000041 |
1.31% |
transition metal ion transport |
GO:0016441 |
1.31% |
posttranscriptional gene silencing |
GO:0110149 |
1.31% |
regulation of biomineralization |
GO:1902042 |
1.30% |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0046782 |
1.30% |
regulation of viral transcription |
GO:0031333 |
1.30% |
negative regulation of protein complex assembly |
GO:0036003 |
1.30% |
positive regulation of transcription from RNA polymerase II promoter in response to stress |
GO:0009620 |
1.30% |
response to fungus |
GO:0042596 |
1.30% |
fear response |
GO:0050870 |
1.30% |
positive regulation of T cell activation |
GO:0051056 |
1.30% |
regulation of small GTPase mediated signal transduction |
GO:1903039 |
1.29% |
positive regulation of leukocyte cell-cell adhesion |
GO:0051817 |
1.29% |
modification of morphology or physiology of other organism involved in symbiotic interaction |
GO:0051851 |
1.29% |
modification by host of symbiont morphology or physiology |
GO:0043549 |
1.29% |
regulation of kinase activity |
GO:0033628 |
1.29% |
regulation of cell adhesion mediated by integrin |
GO:0034599 |
1.29% |
cellular response to oxidative stress |
GO:0035710 |
1.29% |
CD4-positive, alpha-beta T cell activation |
GO:0031401 |
1.29% |
positive regulation of protein modification process |
GO:1904591 |
1.29% |
positive regulation of protein import |
GO:0034968 |
1.29% |
histone lysine methylation |
GO:0042254 |
1.29% |
ribosome biogenesis |
GO:0060967 |
1.29% |
negative regulation of gene silencing by RNA |
GO:0035510 |
1.29% |
DNA dealkylation |
GO:0051489 |
1.29% |
regulation of filopodium assembly |
GO:0043624 |
1.28% |
cellular protein complex disassembly |
GO:0097581 |
1.28% |
lamellipodium organization |
GO:0001562 |
1.28% |
response to protozoan |
GO:0048147 |
1.28% |
negative regulation of fibroblast proliferation |
GO:0034694 |
1.28% |
response to prostaglandin |
GO:0035296 |
1.28% |
regulation of tube diameter |
GO:0016569 |
1.28% |
covalent chromatin modification |
GO:0006268 |
1.28% |
DNA unwinding involved in DNA replication |
GO:0042542 |
1.28% |
response to hydrogen peroxide |
GO:2001236 |
1.28% |
regulation of extrinsic apoptotic signaling pathway |
GO:0018022 |
1.28% |
peptidyl-lysine methylation |
GO:0034440 |
1.27% |
lipid oxidation |
GO:0030316 |
1.27% |
osteoclast differentiation |
GO:0014896 |
1.27% |
muscle hypertrophy |
GO:0071479 |
1.27% |
cellular response to ionizing radiation |
GO:0015918 |
1.27% |
sterol transport |
GO:2000134 |
1.27% |
negative regulation of G1/S transition of mitotic cell cycle |
GO:0001672 |
1.27% |
regulation of chromatin assembly or disassembly |
GO:0031156 |
1.27% |
regulation of sorocarp development |
GO:0046578 |
1.27% |
regulation of Ras protein signal transduction |
GO:0006401 |
1.27% |
RNA catabolic process |
GO:0060969 |
1.27% |
negative regulation of gene silencing |
GO:0030318 |
1.27% |
melanocyte differentiation |
GO:2000191 |
1.26% |
regulation of fatty acid transport |
GO:0098630 |
1.26% |
aggregation of unicellular organisms |
GO:0007052 |
1.26% |
mitotic spindle organization |
GO:1903524 |
1.26% |
positive regulation of blood circulation |
GO:0045823 |
1.26% |
positive regulation of heart contraction |
GO:0014888 |
1.26% |
striated muscle adaptation |
GO:0006022 |
1.26% |
aminoglycan metabolic process |
GO:1903555 |
1.26% |
regulation of tumor necrosis factor superfamily cytokine production |
GO:0071468 |
1.26% |
cellular response to acidic pH |
GO:0007189 |
1.26% |
adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO:0032411 |
1.26% |
positive regulation of transporter activity |
GO:1903338 |
1.25% |
regulation of cell wall organization or biogenesis |
GO:0016101 |
1.25% |
diterpenoid metabolic process |
GO:0002573 |
1.25% |
myeloid leukocyte differentiation |
GO:0051249 |
1.25% |
regulation of lymphocyte activation |
GO:0051649 |
1.25% |
establishment of localization in cell |
GO:0048169 |
1.25% |
regulation of long-term neuronal synaptic plasticity |
GO:0071480 |
1.25% |
cellular response to gamma radiation |
GO:0051149 |
1.25% |
positive regulation of muscle cell differentiation |
GO:0001662 |
1.25% |
behavioral fear response |
GO:1901575 |
1.25% |
organic substance catabolic process |
GO:0051702 |
1.24% |
interaction with symbiont |
GO:0043487 |
1.24% |
regulation of RNA stability |
GO:1903427 |
1.24% |
negative regulation of reactive oxygen species biosynthetic process |
GO:0055024 |
1.24% |
regulation of cardiac muscle tissue development |
GO:0017157 |
1.24% |
regulation of exocytosis |
GO:0051656 |
1.24% |
establishment of organelle localization |
GO:0070192 |
1.24% |
chromosome organization involved in meiotic cell cycle |
GO:0050728 |
1.24% |
negative regulation of inflammatory response |
GO:0001885 |
1.24% |
endothelial cell development |
GO:0003012 |
1.24% |
muscle system process |
GO:0000724 |
1.23% |
double-strand break repair via homologous recombination |
GO:0048261 |
1.23% |
negative regulation of receptor-mediated endocytosis |
GO:0071467 |
1.23% |
cellular response to pH |
GO:0010039 |
1.23% |
response to iron ion |
GO:0030032 |
1.23% |
lamellipodium assembly |
GO:0071364 |
1.23% |
cellular response to epidermal growth factor stimulus |
GO:0006826 |
1.23% |
iron ion transport |
GO:1903959 |
1.23% |
regulation of anion transmembrane transport |
GO:0042326 |
1.23% |
negative regulation of phosphorylation |
GO:0034614 |
1.23% |
cellular response to reactive oxygen species |
GO:1902106 |
1.23% |
negative regulation of leukocyte differentiation |
GO:0010043 |
1.23% |
response to zinc ion |
GO:0090312 |
1.22% |
positive regulation of protein deacetylation |
GO:0035082 |
1.22% |
axoneme assembly |
GO:0007602 |
1.22% |
phototransduction |
GO:0031065 |
1.22% |
positive regulation of histone deacetylation |
GO:1903793 |
1.22% |
positive regulation of anion transport |
GO:0002828 |
1.22% |
regulation of type 2 immune response |
GO:0030168 |
1.22% |
platelet activation |
GO:0006937 |
1.22% |
regulation of muscle contraction |
GO:0051048 |
1.22% |
negative regulation of secretion |
GO:0055021 |
1.22% |
regulation of cardiac muscle tissue growth |
GO:0060045 |
1.22% |
positive regulation of cardiac muscle cell proliferation |
GO:0051291 |
1.22% |
protein heterooligomerization |
GO:0106070 |
1.22% |
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO:0006342 |
1.22% |
chromatin silencing |
GO:0051193 |
1.22% |
regulation of cofactor metabolic process |
GO:0042307 |
1.22% |
positive regulation of protein import into nucleus |
GO:0032731 |
1.21% |
positive regulation of interleukin-1 beta production |
GO:0050873 |
1.21% |
brown fat cell differentiation |
GO:0014743 |
1.21% |
regulation of muscle hypertrophy |
GO:0120161 |
1.21% |
regulation of cold-induced thermogenesis |
GO:0006633 |
1.21% |
fatty acid biosynthetic process |
GO:0016574 |
1.21% |
histone ubiquitination |
GO:0002821 |
1.21% |
positive regulation of adaptive immune response |
GO:0031960 |
1.21% |
response to corticosteroid |
GO:0042423 |
1.21% |
catecholamine biosynthetic process |
GO:0051125 |
1.21% |
regulation of actin nucleation |
GO:0044060 |
1.20% |
regulation of endocrine process |
GO:0016578 |
1.20% |
histone deubiquitination |
GO:0009753 |
1.20% |
response to jasmonic acid |
GO:1902019 |
1.20% |
regulation of cilium-dependent cell motility |
GO:0031113 |
1.20% |
regulation of microtubule polymerization |
GO:0060149 |
1.20% |
negative regulation of posttranscriptional gene silencing |
GO:0071514 |
1.20% |
genetic imprinting |
GO:0051186 |
1.20% |
cofactor metabolic process |
GO:0010714 |
1.20% |
positive regulation of collagen metabolic process |
GO:0009637 |
1.20% |
response to blue light |
GO:2000779 |
1.20% |
regulation of double-strand break repair |
GO:0032732 |
1.20% |
positive regulation of interleukin-1 production |
GO:0002360 |
1.20% |
T cell lineage commitment |
GO:0048193 |
1.20% |
Golgi vesicle transport |
GO:0002824 |
1.20% |
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0032272 |
1.20% |
negative regulation of protein polymerization |
GO:0009308 |
1.19% |
amine metabolic process |
GO:0007288 |
1.19% |
sperm axoneme assembly |
GO:0022898 |
1.19% |
regulation of transmembrane transporter activity |
GO:0072698 |
1.19% |
protein localization to microtubule cytoskeleton |
GO:0045453 |
1.19% |
bone resorption |
GO:0032410 |
1.19% |
negative regulation of transporter activity |
GO:0010228 |
1.19% |
vegetative to reproductive phase transition of meristem |
GO:0050885 |
1.19% |
neuromuscular process controlling balance |
GO:0016102 |
1.18% |
diterpenoid biosynthetic process |
GO:0009251 |
1.18% |
glucan catabolic process |
GO:0048643 |
1.18% |
positive regulation of skeletal muscle tissue development |
GO:0032768 |
1.18% |
regulation of monooxygenase activity |
GO:0043652 |
1.18% |
engulfment of apoptotic cell |
GO:0046635 |
1.18% |
positive regulation of alpha-beta T cell activation |
GO:1903533 |
1.18% |
regulation of protein targeting |
GO:0051155 |
1.17% |
positive regulation of striated muscle cell differentiation |
GO:0034401 |
1.17% |
chromatin organization involved in regulation of transcription |
GO:0010894 |
1.17% |
negative regulation of steroid biosynthetic process |
GO:0071472 |
1.17% |
cellular response to salt stress |
GO:0046822 |
1.17% |
regulation of nucleocytoplasmic transport |
GO:1900182 |
1.17% |
positive regulation of protein localization to nucleus |
GO:0042430 |
1.17% |
indole-containing compound metabolic process |
GO:0031062 |
1.17% |
positive regulation of histone methylation |
GO:1905209 |
1.17% |
positive regulation of cardiocyte differentiation |
GO:0045844 |
1.17% |
positive regulation of striated muscle tissue development |
GO:0060043 |
1.17% |
regulation of cardiac muscle cell proliferation |
GO:0048026 |
1.16% |
positive regulation of mRNA splicing, via spliceosome |
GO:0010410 |
1.16% |
hemicellulose metabolic process |
GO:0019226 |
1.16% |
transmission of nerve impulse |
GO:1902414 |
1.16% |
protein localization to cell junction |
GO:0050931 |
1.16% |
pigment cell differentiation |
GO:0071826 |
1.16% |
ribonucleoprotein complex subunit organization |
GO:0070301 |
1.16% |
cellular response to hydrogen peroxide |
GO:0045936 |
1.16% |
negative regulation of phosphate metabolic process |
GO:0051384 |
1.16% |
response to glucocorticoid |
GO:0010563 |
1.16% |
negative regulation of phosphorus metabolic process |
GO:0007033 |
1.16% |
vacuole organization |
GO:0008277 |
1.16% |
regulation of G protein-coupled receptor signaling pathway |
GO:0043488 |
1.16% |
regulation of mRNA stability |
GO:0009657 |
1.16% |
plastid organization |
GO:1990928 |
1.15% |
response to amino acid starvation |
GO:0045600 |
1.15% |
positive regulation of fat cell differentiation |
GO:0050854 |
1.15% |
regulation of antigen receptor-mediated signaling pathway |
GO:0098926 |
1.15% |
postsynaptic signal transduction |
GO:0061037 |
1.15% |
negative regulation of cartilage development |
GO:0098693 |
1.15% |
regulation of synaptic vesicle cycle |
GO:1905897 |
1.15% |
regulation of response to endoplasmic reticulum stress |
GO:1904063 |
1.15% |
negative regulation of cation transmembrane transport |
GO:0032526 |
1.15% |
response to retinoic acid |
GO:0007064 |
1.14% |
mitotic sister chromatid cohesion |
GO:0043489 |
1.14% |
RNA stabilization |
GO:0034198 |
1.14% |
cellular response to amino acid starvation |
GO:0031935 |
1.14% |
regulation of chromatin silencing |
GO:0048010 |
1.14% |
vascular endothelial growth factor receptor signaling pathway |
GO:0009832 |
1.14% |
plant-type cell wall biogenesis |
GO:2000573 |
1.14% |
positive regulation of DNA biosynthetic process |
GO:0042403 |
1.14% |
thyroid hormone metabolic process |
GO:0009713 |
1.14% |
catechol-containing compound biosynthetic process |
GO:0060142 |
1.14% |
regulation of syncytium formation by plasma membrane fusion |
GO:0032722 |
1.13% |
positive regulation of chemokine production |
GO:0015908 |
1.13% |
fatty acid transport |
GO:0030865 |
1.13% |
cortical cytoskeleton organization |
GO:0001556 |
1.13% |
oocyte maturation |
GO:0050907 |
1.13% |
detection of chemical stimulus involved in sensory perception |
GO:1900117 |
1.13% |
regulation of execution phase of apoptosis |
GO:0032760 |
1.13% |
positive regulation of tumor necrosis factor production |
GO:0044272 |
1.13% |
sulfur compound biosynthetic process |
GO:0050996 |
1.13% |
positive regulation of lipid catabolic process |
GO:1901607 |
1.13% |
alpha-amino acid biosynthetic process |
GO:0034104 |
1.13% |
negative regulation of tissue remodeling |
GO:0097746 |
1.13% |
regulation of blood vessel diameter |
GO:0010611 |
1.13% |
regulation of cardiac muscle hypertrophy |
GO:0045939 |
1.12% |
negative regulation of steroid metabolic process |
GO:0048015 |
1.12% |
phosphatidylinositol-mediated signaling |
GO:1904589 |
1.12% |
regulation of protein import |
GO:2001237 |
1.12% |
negative regulation of extrinsic apoptotic signaling pathway |
GO:0002694 |
1.12% |
regulation of leukocyte activation |
GO:0033555 |
1.12% |
multicellular organismal response to stress |
GO:0030001 |
1.12% |
metal ion transport |
GO:0006402 |
1.12% |
mRNA catabolic process |
GO:0048311 |
1.12% |
mitochondrion distribution |
GO:0033233 |
1.12% |
regulation of protein sumoylation |
GO:0016540 |
1.12% |
protein autoprocessing |
GO:0071216 |
1.12% |
cellular response to biotic stimulus |
GO:0051016 |
1.12% |
barbed-end actin filament capping |
GO:0055069 |
1.11% |
zinc ion homeostasis |
GO:0006906 |
1.11% |
vesicle fusion |
GO:0009451 |
1.11% |
RNA modification |
GO:0000398 |
1.11% |
mRNA splicing, via spliceosome |
GO:0050911 |
1.11% |
detection of chemical stimulus involved in sensory perception of smell |
GO:0019344 |
1.11% |
cysteine biosynthetic process |
GO:0070168 |
1.11% |
negative regulation of biomineral tissue development |
GO:0030007 |
1.11% |
cellular potassium ion homeostasis |
GO:0071731 |
1.11% |
response to nitric oxide |
GO:2001021 |
1.11% |
negative regulation of response to DNA damage stimulus |
GO:0031396 |
1.11% |
regulation of protein ubiquitination |
GO:0042119 |
1.11% |
neutrophil activation |
GO:0030511 |
1.11% |
positive regulation of transforming growth factor beta receptor signaling pathway |
GO:0019954 |
1.10% |
asexual reproduction |
GO:0043967 |
1.10% |
histone H4 acetylation |
GO:0050919 |
1.10% |
negative chemotaxis |
GO:0050863 |
1.10% |
regulation of T cell activation |
GO:0003341 |
1.10% |
cilium movement |
GO:1903578 |
1.10% |
regulation of ATP metabolic process |
GO:1902807 |
1.10% |
negative regulation of cell cycle G1/S phase transition |
GO:0032965 |
1.10% |
regulation of collagen biosynthetic process |
GO:0030500 |
1.10% |
regulation of bone mineralization |
GO:0000002 |
1.10% |
mitochondrial genome maintenance |
GO:0031152 |
1.10% |
aggregation involved in sorocarp development |
GO:0010212 |
1.09% |
response to ionizing radiation |
GO:0070988 |
1.09% |
demethylation |
GO:1902041 |
1.09% |
regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0030517 |
1.09% |
negative regulation of axon extension |
GO:0060998 |
1.09% |
regulation of dendritic spine development |
GO:0002437 |
1.09% |
inflammatory response to antigenic stimulus |
GO:0006012 |
1.09% |
galactose metabolic process |
GO:0098781 |
1.09% |
ncRNA transcription |
GO:0095500 |
1.09% |
acetylcholine receptor signaling pathway |
GO:0043372 |
1.09% |
positive regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0030010 |
1.09% |
establishment of cell polarity |
GO:0009988 |
1.09% |
cell-cell recognition |
GO:0110151 |
1.08% |
positive regulation of biomineralization |
GO:0048255 |
1.08% |
mRNA stabilization |
GO:0006376 |
1.08% |
mRNA splice site selection |
GO:0016239 |
1.08% |
positive regulation of macroautophagy |
GO:0009812 |
1.08% |
flavonoid metabolic process |
GO:0002250 |
1.08% |
adaptive immune response |
GO:0010559 |
1.08% |
regulation of glycoprotein biosynthetic process |
GO:0034767 |
1.08% |
positive regulation of ion transmembrane transport |
GO:0120162 |
1.08% |
positive regulation of cold-induced thermogenesis |
GO:0007020 |
1.08% |
microtubule nucleation |
GO:0007188 |
1.08% |
adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO:0048661 |
1.08% |
positive regulation of smooth muscle cell proliferation |
GO:0051952 |
1.08% |
regulation of amine transport |
GO:0042771 |
1.08% |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO:0006582 |
1.08% |
melanin metabolic process |
GO:0042128 |
1.08% |
nitrate assimilation |
GO:0014065 |
1.07% |
phosphatidylinositol 3-kinase signaling |
GO:0000160 |
1.07% |
phosphorelay signal transduction system |
GO:1903846 |
1.07% |
positive regulation of cellular response to transforming growth factor beta stimulus |
GO:0071870 |
1.07% |
cellular response to catecholamine stimulus |
GO:0007030 |
1.07% |
Golgi organization |
GO:0009057 |
1.07% |
macromolecule catabolic process |
GO:0019220 |
1.07% |
regulation of phosphate metabolic process |
GO:0014850 |
1.07% |
response to muscle activity |
GO:0042325 |
1.07% |
regulation of phosphorylation |
GO:0010824 |
1.07% |
regulation of centrosome duplication |
GO:0048660 |
1.07% |
regulation of smooth muscle cell proliferation |
GO:0055085 |
1.07% |
transmembrane transport |
GO:0048145 |
1.06% |
regulation of fibroblast proliferation |
GO:0043268 |
1.06% |
positive regulation of potassium ion transport |
GO:0010469 |
1.06% |
regulation of signaling receptor activity |
GO:0042391 |
1.06% |
regulation of membrane potential |
GO:0060079 |
1.06% |
excitatory postsynaptic potential |
GO:0022613 |
1.06% |
ribonucleoprotein complex biogenesis |
GO:0032088 |
1.06% |
negative regulation of NF-kappaB transcription factor activity |
GO:0032508 |
1.06% |
DNA duplex unwinding |
GO:1902017 |
1.06% |
regulation of cilium assembly |
GO:0045839 |
1.06% |
negative regulation of mitotic nuclear division |
GO:0086091 |
1.06% |
regulation of heart rate by cardiac conduction |
GO:0006575 |
1.06% |
cellular modified amino acid metabolic process |
GO:0044458 |
1.05% |
motile cilium assembly |
GO:0042832 |
1.05% |
defense response to protozoan |
GO:0007131 |
1.05% |
reciprocal meiotic recombination |
GO:0002832 |
1.05% |
negative regulation of response to biotic stimulus |
GO:1902532 |
1.05% |
negative regulation of intracellular signal transduction |
GO:0032673 |
1.05% |
regulation of interleukin-4 production |
GO:0110150 |
1.05% |
negative regulation of biomineralization |
GO:0050848 |
1.05% |
regulation of calcium-mediated signaling |
GO:1990778 |
1.05% |
protein localization to cell periphery |
GO:1901657 |
1.05% |
glycosyl compound metabolic process |
GO:0055023 |
1.05% |
positive regulation of cardiac muscle tissue growth |
GO:0051973 |
1.05% |
positive regulation of telomerase activity |
GO:0061024 |
1.05% |
membrane organization |
GO:0009086 |
1.05% |
methionine biosynthetic process |
GO:0051289 |
1.04% |
protein homotetramerization |
GO:0002090 |
1.04% |
regulation of receptor internalization |
GO:0071875 |
1.04% |
adrenergic receptor signaling pathway |
GO:0070613 |
1.04% |
regulation of protein processing |
GO:0042136 |
1.04% |
neurotransmitter biosynthetic process |
GO:0034695 |
1.04% |
response to prostaglandin E |
GO:0031288 |
1.04% |
sorocarp morphogenesis |
GO:1901222 |
1.04% |
regulation of NIK/NF-kappaB signaling |
GO:0055025 |
1.04% |
positive regulation of cardiac muscle tissue development |
GO:2001239 |
1.04% |
regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0010150 |
1.04% |
leaf senescence |
GO:0007062 |
1.03% |
sister chromatid cohesion |
GO:0019730 |
1.03% |
antimicrobial humoral response |
GO:1901991 |
1.03% |
negative regulation of mitotic cell cycle phase transition |
GO:0051693 |
1.03% |
actin filament capping |
GO:0051174 |
1.03% |
regulation of phosphorus metabolic process |
GO:0042306 |
1.03% |
regulation of protein import into nucleus |
GO:0071320 |
1.03% |
cellular response to cAMP |
GO:2000171 |
1.03% |
negative regulation of dendrite development |
GO:1905954 |
1.03% |
positive regulation of lipid localization |
GO:1901099 |
1.03% |
negative regulation of signal transduction in absence of ligand |
GO:0060999 |
1.03% |
positive regulation of dendritic spine development |
GO:0032392 |
1.02% |
DNA geometric change |
GO:0010226 |
1.02% |
response to lithium ion |
GO:0030947 |
1.02% |
regulation of vascular endothelial growth factor receptor signaling pathway |
GO:1903018 |
1.02% |
regulation of glycoprotein metabolic process |
GO:0044265 |
1.02% |
cellular macromolecule catabolic process |
GO:0055114 |
1.02% |
oxidation-reduction process |
GO:0003351 |
1.02% |
epithelial cilium movement involved in extracellular fluid movement |
GO:0032479 |
1.02% |
regulation of type I interferon production |
GO:0097549 |
1.02% |
chromatin organization involved in negative regulation of transcription |
GO:0043901 |
1.02% |
negative regulation of multi-organism process |
GO:0070371 |
1.02% |
ERK1 and ERK2 cascade |
GO:0071868 |
1.02% |
cellular response to monoamine stimulus |
GO:0030501 |
1.02% |
positive regulation of bone mineralization |
GO:0032412 |
1.02% |
regulation of ion transmembrane transporter activity |
GO:0019217 |
1.02% |
regulation of fatty acid metabolic process |
GO:0071669 |
1.02% |
plant-type cell wall organization or biogenesis |
GO:0006936 |
1.02% |
muscle contraction |
GO:0008652 |
1.02% |
cellular amino acid biosynthetic process |
GO:0030835 |
1.02% |
negative regulation of actin filament depolymerization |
GO:0010712 |
1.01% |
regulation of collagen metabolic process |
GO:1903509 |
1.01% |
liposaccharide metabolic process |
GO:0051403 |
1.01% |
stress-activated MAPK cascade |
GO:0038179 |
1.01% |
neurotrophin signaling pathway |
GO:0006664 |
1.01% |
glycolipid metabolic process |
GO:0030728 |
1.01% |
ovulation |
GO:0045732 |
1.01% |
positive regulation of protein catabolic process |
GO:1903037 |
1.01% |
regulation of leukocyte cell-cell adhesion |
GO:2000105 |
1.01% |
positive regulation of DNA-dependent DNA replication |
GO:0090174 |
1.01% |
organelle membrane fusion |
GO:0010569 |
1.01% |
regulation of double-strand break repair via homologous recombination |
GO:0071383 |
1.01% |
cellular response to steroid hormone stimulus |
GO:0010447 |
1.01% |
response to acidic pH |
GO:0030301 |
1.01% |
cholesterol transport |
GO:1902473 |
1.01% |
regulation of protein localization to synapse |
GO:0051279 |
1.01% |
regulation of release of sequestered calcium ion into cytosol |
GO:0000375 |
1.00% |
RNA splicing, via transesterification reactions |
GO:0006910 |
1.00% |
phagocytosis, recognition |
GO:0007187 |
1.00% |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0009723 |
1.00% |
response to ethylene |
GO:0045724 |
1.00% |
positive regulation of cilium assembly |
GO:0043502 |
1.00% |
regulation of muscle adaptation |
GO:0045671 |
1.00% |
negative regulation of osteoclast differentiation |
GO:0071466 |
1.00% |
cellular response to xenobiotic stimulus |
GO:0031343 |
1.00% |
positive regulation of cell killing |